GLP-1 Market
LLY $1409.38 ▼ -0.1% NVO $40.19 ▼ -0.6% PFE $30.00 ▼ -2.2% VKTX $26.09 ▼ -2.8% KLRA $12.58 ▲ +3.5% GPCR $20.35 ▼ -0.6% RHHBY $59.18 ▼ -2.5%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Hormonal therapy

Company
University of Colorado, Denver
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
85 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

85 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Nov 4, 2026

Find a Clinical Trial Near Me

See recruiting studies for Hormonal therapy and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02476786

    Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

    Not yet reported Washington University School of Medicine 50 participants Est. completion 2032-07-31 1 site
    Other conditions: Breast Cancer, Cancer of Breast, Breast Neoplasms, Cancer of the Breast
    View official trial listing →
  • Recruiting NCT NCT02535221

    Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer

    Not yet reported Peking University 234 participants Est. completion 2026-12-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04483804

    Application of Radiomics in Breast Cancer

    Second Affiliated Hospital, Zhejiang University, School of Medicine 2000 participants Est. completion 2028-12 1 site
    Other conditions: Breast Cancer, Ultrasound, Elastography, Pathology, Radiomics
    View official trial listing →
  • Recruiting NCT NCT04606446

    Study of PF-07248144 in Advanced or Metastatic Solid Tumors

    Not yet reported Pfizer 320 participants Est. completion 2029-08-27 43 sites
    Other conditions: Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT04775355

    Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate Cancer

    City of Hope Medical Center 30 participants Est. completion 2026-12-01 1 site
    Other conditions: Stage I Prostate Cancer AJCC v7, Stage II Prostate Cancer AJCC v7, Stage IIA Prostate Cancer AJCC v7, Stage IIB Prostate Cancer AJCC v7, Stage III Prostate Cancer AJCC v7, Stage IV Prostate Cancer AJCC v7
    View official trial listing →
  • Recruiting NCT NCT04838249

    Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System

    University of Leipzig 80 participants Est. completion 2026-05 1 site
    Other conditions: Transsexualism, Transgenderism, Adiposity, Eating Behavior, Arterial Stiffness, Microangiopathy
    View official trial listing →
  • Recruiting NCT NCT04852887

    De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

    Not yet reported NRG Oncology 1670 participants Est. completion 2041-07 832 sites
    Other conditions: Stage I Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04935164

    Comparative Study of Gender Identity Disorder Versus Control

    Centre Hospitalier Henri Laborit 120 participants Est. completion 2029-12 1 site
    Other conditions: Gender Dysphoria, Adult
    View official trial listing →
  • Recruiting NCT NCT04968964

    Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing

    Not yet reported Washington University School of Medicine 55 participants Est. completion 2030-09-30 1 site
    Other conditions: Breast Cancer, Cancer of the Breast
    View official trial listing →
  • Recruiting NCT NCT04985058

    Real-world Data in Patients With Breast Cancer Treated With Abemaciclib

    Hellenic Cooperative Oncology Group 108 participants Est. completion 2027-07-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05071105

    SBRT in Early Breast Cancer in Elderly Women

    Not yet reported University of Rome Tor Vergata 30 participants Est. completion 2026-12-31 1 site
    Other conditions: Breast Neoplasm Female
    View official trial listing →
  • Recruiting NCT NCT05280028

    HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness

    Far Eastern Memorial Hospital 100 participants Est. completion 2026-12-31 1 site
    Other conditions: Menopausal Syndrome
    View official trial listing →
  • Recruiting NCT NCT05345860

    Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer

    Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 300 participants Est. completion 2027-03-24 3 sites
    Other conditions: Early-stage Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05417308

    Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer

    Not yet reported Ohio State University Comprehensive Cancer Center 50 participants Est. completion 2027-12-31 1 site
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Endocrine Therapy-Induced Alopecia, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT05442463

    Hormone Therapy and Angiotensin-Dependent Arterial and Renal Vasoconstriction in Humans

    University of Calgary 200 participants Est. completion 2025-11-30 1 site
    Other conditions: Hormone Therapy
    View official trial listing →
  • Recruiting NCT NCT05467891

    Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

    Not yet reported Oana Danciu 200 participants Est. completion 2029-08-15 21 sites
    Other conditions: Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05534321

    Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease

    Not yet reported, Not yet reported Baptist Health South Florida 74 participants Est. completion 2028-09 1 site
    Other conditions: Spine Metastases
    View official trial listing →
  • Recruiting NCT NCT05587751

    Evaluation of Gender-Affirming Treatments on Pulmonary Function in Transgender and Gender Diverse Patients

    Not yet reported Mayo Clinic 44 participants Est. completion 2027-07 1 site
    Other conditions: Hormonal Gender-Affirming Therapy
    View official trial listing →
  • Recruiting NCT NCT05603078

    A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN)

    Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 102 participants Est. completion 2028-07 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Recruiting NCT NCT05621564

    Pre-operative Therapy in Breast Cancer

    RenJi Hospital 6032 participants Est. completion 2030-11 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05649605

    Early Mental Response - The EMRE Study

    Not yet reported Karolinska University Hospital 70 participants Est. completion 2026-12-30 1 site
    Other conditions: Gender Dysphoria, Gender Identity, Gender Issues
    View official trial listing →
  • Recruiting NCT NCT05726292

    A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

    Not yet reported University of Chicago 90 participants Est. completion 2028-04-01 4 sites
    Other conditions: Prostate Cancer, Prostate Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT05860465

    Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer

    Not yet reported, Not yet reported Shanghai Pharmaceuticals Holding Co., Ltd 254 participants Est. completion 2026-12-30 22 sites
    Other conditions: Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05878314

    Impact of Endocrine Therapy, Menstrual Cycle, PAM50, Ki67 on Treatment Decisions in HR+ and HER2- Breast Cancer

    University Hospital Tuebingen 504 participants Est. completion 2035-04 1 site
    Other conditions: Hormone Receptor Positive HER-2 Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05879926

    Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

    Not yet reported NRG Oncology 3960 participants Est. completion 2034-07 1261 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05891093

    Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)

    Not yet reported Fudan University 766 participants Est. completion 2031-05-31 15 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05904964

    Disitamab Vedotin (RC48) in Hormone Receptor Positive, HER2-low Metastatic Breast Cancer (the Rosy Trial)

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 288 participants Est. completion 2030-03-01 3 sites
    Other conditions: HR Positive/HER2 Low Expression Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06033287

    Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC.

    Hunan Cancer Hospital 300 participants Est. completion 2025-12-31 1 site
    Other conditions: Breast Cancer, Endocrine Therapy, CDK4/6 Inhibitors, Subsequent Treatment
    View official trial listing →
  • Recruiting NCT NCT06044623

    Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients

    Not yet reported Region Örebro County 495 participants Est. completion 2029-05-31 12 sites
    Other conditions: Metastatic Breast Cancer, Advanced Breast Cancer, Quality of Life, Toxicity, Older Patients
    View official trial listing →
  • Recruiting NCT NCT06162559

    Neoadjuvant Trastuzumab, Pertuzumab and Tucatinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-4 Study

    Not yet reported The Netherlands Cancer Institute 30 participants Est. completion 2036-05 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06245681

    Effects of Cross-sex Hormone Treatment on Cardiac Function, Myocardial and Hepatic Fat Content

    Medical University of Vienna 40 participants Est. completion 2028-10-20 1 site
    Other conditions: Gender Dysphoria
    View official trial listing →
  • Recruiting NCT NCT06306612

    CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer

    Not yet reported RenJi Hospital 192 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT06350825

    Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 200 participants Est. completion 2028-12-31 1 site
    Other conditions: Metastatic Prostate Cancer, Therapy, Directly Observed
    View official trial listing →
  • Recruiting NCT NCT06361940

    Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer

    Not yet reported Medical College of Wisconsin 185 participants Est. completion 2028-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06480513

    Cancer Of the BReast Asanas Study (COBRA)

    Not yet reported UMC Utrecht 140 participants Est. completion 2027-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06486883

    Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype

    Not yet reported MedSIR 200 participants Est. completion 2028-01 79 sites
    Other conditions: Advanced Breast Cancer, Advanced Breast Carcinoma, Hormone Receptor Positive Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06517212

    Tirzepatide Weight Loss for MRD+ Early Breast Cancer

    Not yet reported Baylor Research Institute 48 participants Est. completion 2030-12-31 1 site
    Other conditions: Breast Cancer, Breast Neoplasms, Breast Cancers
    View official trial listing →
  • Recruiting NCT NCT06530459

    The MUSE Study for Menopausal Arthralgia

    Not yet reported, Not yet reported National University Hospital, Singapore 100 participants Est. completion 2028-04 1 site
    Other conditions: Arthralgia, Menopause, Perimenopausal Disorder, Joint Pain, Postmenopausal Disorder
    View official trial listing →
  • Recruiting NCT NCT06548919

    Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer

    SciClone Pharmaceuticals 450 participants Est. completion 2027-12-31 1 site
    Other conditions: ESR1 Gene Mutation, Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06590857

    Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

    Not yet reported, Not yet reported RayzeBio, Inc. 64 participants Est. completion 2033-11 31 sites
    Other conditions: Metastatic Breast Cancer, HER2-negative Breast Cancer, ER+ Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer With Bone Involvement, Bone Metastases in Subjects With Advanced Breast Cancer, ER-Positive HER2-Negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, Hormone-sensitive Metastatic Breast Cancer, Hormone-Sensitive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06702995

    Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate Cancer

    Not yet reported, Not yet reported Evopoint Biosciences Inc. 307 participants Est. completion 2027-07-13 2 sites
    Other conditions: Metastatic Castrate-Resistant Prostate Cancer, mCRPC (Metastatic Castration-resistant Prostate Cancer)
    View official trial listing →
  • Recruiting NCT NCT06774053

    Swiss ProspectivE Cohort of TRAnsgender and Gender Diverse Individuals - The SPECTRA Study

    University Hospital, Basel, Switzerland 600 participants Est. completion 2046-01 3 sites
    Other conditions: Transgender Individuals, Gender Incongruence
    View official trial listing →
  • Recruiting NCT NCT06781996

    A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 180 participants Est. completion 2026-12-15 1 site
    Other conditions: Breast Cancer, Breast Cancer Early Stage Breast Cancer (Stage 1-3)
    View official trial listing →
  • Recruiting NCT NCT06792201

    Evaluation of Sarcopenia in Women in Different Stages of Life and in Hormonal Therapy or Not

    Not yet reported IRCCS Azienda Ospedaliero-Universitaria di Bologna 180 participants Est. completion 2026-06-14 1 site
    Other conditions: Sarcopenia
    View official trial listing →
  • Recruiting NCT NCT06806930

    Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)

    Not yet reported George Washington University 90 participants Est. completion 2028-10 1 site
    Other conditions: Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, Carcinoma, Breast
    View official trial listing →
  • Recruiting NCT NCT06818682

    Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial

    Not yet reported Tata Memorial Centre 206 participants Est. completion 2035-01-01 1 site
    Other conditions: Prostate Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06843967

    A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 54 participants Est. completion 2028-08-19 7 sites
    Obstructive sleep apnea
    View official trial listing →
  • Recruiting NCT NCT06856174

    Menopausal HT for Women Living With HIV (HoT)

    Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 105 participants Est. completion 2027-09-20 23 sites
    Other conditions: HIV Infection, Menopause
    View official trial listing →
  • Recruiting NCT NCT06897488

    EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial

    Not yet reported M.D. Anderson Cancer Center 300 participants Est. completion 2030-12-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06914440

    Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer

    Not yet reported Xijing Hospital 27 participants Est. completion 2030-12 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06931340

    Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

    Not yet reported Alliance for Clinical Trials in Oncology 1260 participants Est. completion 2039-05-08 214 sites
    Other conditions: Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT06939257

    Pain Outcomes Associated With Exogenous Hormone Therapy in Adults

    University of Kansas Medical Center 200 participants Est. completion 2029-09-16 1 site
    Other conditions: Pain, Gender Minority Individuals
    View official trial listing →
  • Recruiting NCT NCT06975111

    Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

    Not yet reported, Not yet reported University of Colorado, Denver 200 participants Est. completion 2030-10-01 3 sites Stand-alone
    Other conditions: Menopause, Menopause Hot Flashes, Menopause Related Conditions, Cardiovascular
    View official trial listing →
  • Recruiting NCT NCT07012720

    Research on the Potential Mechanisms Underlying the Efficacy Differences in Specific Neoadjuvant Treatment Regimens for Different Subtypes of Breast Cancer

    Not yet reported Xijing Hospital 71 participants Est. completion 2027-04-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07019363

    CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS)

    Not yet reported Fudan University 1903 participants Est. completion 2033-04-15 1 site
    Other conditions: Breast Cancer, Adjuvant Therapy
    View official trial listing →
  • Recruiting NCT NCT07077876

    Surgical and Obstetric Outcomes in Endometrial Adenocarcinoma and Atypical Endometrial Hyperplasia With Conservative Treatment

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100 participants Est. completion 2026-01-20 1 site
    Other conditions: Endometrial Adenocarcinoma, Endometrial Hyperplasia, Fertility Preservation, Conservative Treatment Therapy
    View official trial listing →
  • Recruiting NCT NCT07148921

    Perception of Pain During Gender Affirming Hormone Therapy

    Medical University of Vienna 40 participants Est. completion 2026-03 1 site
    Other conditions: Transgender Persons, Pain Threshold, Perception of Pain, Sex Hormones
    View official trial listing →
  • Recruiting NCT NCT07152340

    The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.

    Not yet reported Shanghai Changzheng Hospital 64 participants Est. completion 2030-05-01 2 sites
    Other conditions: Thyroid Associated Ophthalmopathies
    View official trial listing →
  • Recruiting NCT NCT07152366

    Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment.

    Not yet reported Shanghai Changzheng Hospital 96 participants Est. completion 2035-04-15 1 site
    Other conditions: Thyroid Associated Ophthalmopathies
    View official trial listing →
  • Recruiting NCT NCT07162987

    Prehabilitation to Patients With Prostate Cancer

    Not yet reported Odense University Hospital 20 participants Est. completion 2026-11 3 sites
    Other conditions: Prostate Cancer (Diagnosis)
    View official trial listing →
  • Recruiting NCT NCT07174336

    A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

    Not yet reported Eli Lilly and Company 800 participants Est. completion 2033-05 363 sites
    Other conditions: Breast Neoplasms, Neoplasm Metastasis
    View official trial listing →
  • Recruiting NCT NCT07235176

    Phase Ib/II Clinical Study of QLS1304 Combined With Endocrine Therapy in the Treatment of ER+/HER2- Breast Cancer Patients

    Not yet reported, Not yet reported Qilu Pharmaceutical Co., Ltd. 300 participants Est. completion 2031-12-30 1 site
    Other conditions: Advanced ER+/HER2- Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07237269

    Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer

    Not yet reported University of Nebraska 140 participants Est. completion 2033-04-03 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT07242118

    Conformal Ablative Radiotherapy in Older Women (CARMEN) With Breast Cancer Undergoing Non-Operative Management

    Not yet reported University of Kansas Medical Center 18 participants Est. completion 2027-10 2 sites Stand-alone
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Recruiting NCT NCT07243002

    Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters.

    Novartis Pharmaceuticals 3000 participants Est. completion 2030-04-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07295457

    Clinical Trial Evaluating the Efficacy and Implementation of an Early Adapted Physical Activity to Prevent and Manage Aromatase Inhibitor-induced Musculoskeletal Pain in Breast Cancer (APIS)

    Not yet reported Hospices Civils de Lyon 182 participants Est. completion 2029-07 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07333521

    Assessment of Body Composition in Children Treated With Growth Hormone for the Indication of Isolated Non-acquired Growth Hormone Deficiency.

    Assistance Publique - Hôpitaux de Paris 200 participants Est. completion 2034-01-13 1 site
    Other conditions: Isolated Non-acquired Growth Hormone Deficiency
    View official trial listing →
  • Recruiting NCT NCT07347600

    A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer

    Hoffmann-La Roche 500 participants Est. completion 2029-12-31 32 sites
    Other conditions: Locally Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07400419

    Effects of Resistance Exercise Among TGD Individuals Initiating Estrogen-Based Gender-Affirming Hormone Therapy

    Not yet reported Massachusetts General Hospital 40 participants Est. completion 2028-04-01 1 site
    Other conditions: Muscle Mass and Strength
    View official trial listing →
  • Recruiting NCT NCT07410039

    Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study

    Not yet reported Chinese PLA General Hospital 200 participants Est. completion 2029-06-30 1 site
    Other conditions: Neuromyelitis Optica Spectrum Disorder Attack
    View official trial listing →
  • Recruiting NCT NCT07477626

    Radiotherapy After Prostatectomy for Node Positive Prostate Cancer

    Not yet reported Sun Yat-sen University 372 participants Est. completion 2038-12-31 13 sites Stand-alone
    Other conditions: Prostate Cancer (Post Prostatectomy), Radiotherapy; Image-Guided, Prostate Cancer Non-Metastatic, Androgen Deprivation Therapy, Lymph Node Positive
    View official trial listing →
  • Recruiting NCT NCT07483307

    A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 176 participants Est. completion 2030-03-13 7 sites
    Other conditions: Breast Cancer, HER2-negative Breast Cancer, HER2 Negative Breast Carcinoma, ER+ Breast Cancer, Lobular Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07502820

    The POWER Trial: Personalised Dose Optimisation With Adjuvant Tamoxifen Therapy in Breast cancER

    Not yet reported Karolinska Institutet 1100 participants Est. completion 2036-08 4 sites
    Other conditions: Breast Cancer, Adjuvant Drug Therapy
    View official trial listing →
  • Recruiting NCT NCT07563621

    Determining the Extent of the Genitourinary Syndrome of Menopause Burden in Breast Cancer Survivors

    Jessa Hospital 264 participants Est. completion 2028-08-31 1 site
    Other conditions: Genitourinary Syndrome of Menopause (GSM), Breast Cancer, Vulvovaginal Atrophy, Genitourinary Syndrome of Menopause
    View official trial listing →
  • Recruiting NCT NCT07592403

    Efficacy of Pulsed Electromagnetic Field Therapy on Women With Endometriosis

    Not yet reported Beni-Suef University 60 participants Est. completion 2027-01-30 1 site Stand-alone
    Other conditions: Endometriosis, Pulsed Electromagnetic Therapy, Trans Perineal Ultrasound
    View official trial listing →
  • Recruiting NCT NCT07597993

    BEYOND Study: A Multicentre, Prospective, Observational Study of Real-world Treatment Patterns and Outcomes of Trastuzumab Deruxtecan in Patients With HR Positive, HER2-low or Ultra-low Metastatic Breast Cancer Previously Treated With Endocrine Therapy

    AstraZeneca 109 participants Est. completion 2029-03-31 9 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07646171

    EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+) Metastatic Breast Cancer (MBC)

    Tel-Aviv Sourasky Medical Center 19 participants Est. completion 2027-12-31 1 site
    Other conditions: Hormone Receptor Positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07683754

    T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd

    Not yet reported Daiichi Sankyo 200 participants Est. completion 2030-08-28 5 sites
    Other conditions: Advanced Breast Cancer, Metastatic Breast Cancer, HER2 Positive, HR Positive
    View official trial listing →
  • Recruiting NCT NCT07762885

    Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving Surgery

    Not yet reported Fudan University 636 participants Est. completion 2036-06 1 site
    Other conditions: Ductal Carcinoma In Situ, DCIS
    View official trial listing →
  • Recruiting NCT NCT07796880

    Neoadjuvant Culmerciclib Combined With Endocrine Therapy for Hormone Receptor-Positive， Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 80 participants Est. completion 2033-03-15 1 site
    Other conditions: Hormone Receptor-Positive Breast Cancer, HER2 Low Breast Carcinoma, Early-Stage Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07810959

    Breast and Vascular Effects of Menopausal Hormone Therapy in Postmenopausal Women

    Sanliurfa Mehmet Akif Inan Education and Research Hospital 120 participants Est. completion 2027-05-31 1 site
    Other conditions: Menopause
    View official trial listing →
  • Recruiting NCT NCT07827573

    A Study to Learn How Well Participants With a Specific Type of Early Breast Cancer (ER-Positive, HER2-Negative) Tolerate and Stay on Treatment With Giredestrant and How They Feel During Treatment

    Not yet reported Hoffmann-La Roche 1500 participants Est. completion 2032-11-30 1 site
    Other conditions: Early Breast Cancer, Estrogen Receptor-Positive Breast Cancer, HER2-Negative Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT07831902

    Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features (RAINBO) - NSMP-ORANGE Trial: Comparing Radiotherapy With Oral Progestin Tablets vs. the Current Standard Care, Radiotherapy and Chemotherapy, in Patients With NSMP Endometrial Cancer

    Not yet reported University College, London 600 participants Est. completion 2034-12 12 sites
    Other conditions: Endometrial Cancer, Uterine Neoplasms
    View official trial listing →
  • Recruiting NCT NCT07871435

    GI-102 (CD80-IgG4 Fc-IL2v3) in Combination With Pasritamig in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) (JET-201)

    Not yet reported, Not yet reported GI Innovation, Inc. 107 participants Est. completion 2029-09-30 6 sites
    Other conditions: Metastatic Castration-resistant Prostate Cancer (mCRPC)
    View official trial listing →
  • Recruiting NCT NCT07893327

    Evaluation of the Effect of Regular Physical Exercise in Breast Cancer.

    Not yet reported Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares 150 participants Est. completion 2028-12 1 site
    Other conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)
    View official trial listing →
  • Completed NCT NCT00000399

    Bone Estrogen Strength Training

    Not yet reported University of Arizona 300 participants Est. completion 2001-01 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00000421

    Serologically Active, Clinically Stable Systemic Lupus Erythematosus

    Not yet reported NYU Langone Health 154 participants Est. completion 2003-08 3 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00001305

    Growth Hormone Therapy in Osteogenesis Imperfecta

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 42 participants Est. completion 2017-05-19 1 site
    Other conditions: Osteogenesis Imperfecta
    View official trial listing →
  • Completed NCT NCT00001890

    Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 80 participants Est. completion 2001-03 1 site
    Other conditions: Atherosclerosis, Chlamydia Infections, Cytomegalovirus Infections, Pneumonia, Bacterial, Postmenopause
    View official trial listing →
  • Completed NCT NCT00002633

    Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer

    Not yet reported NCIC Clinical Trials Group 361 participants Est. completion 2012-01-06 15 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00002651

    SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer

    Not yet reported SWOG Cancer Research Network 3040 participants Est. completion 2013-06 14 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00002855

    Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer

    Not yet reported M.D. Anderson Cancer Center 306 participants Est. completion 2005-06 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00003323

    Hormone Therapy in Treating Patients With Prostate Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 101 participants Est. completion 2010-03 43 sites
    Other conditions: Prostate Cancer, Sexual Dysfunction and Infertility
    View official trial listing →
  • Completed NCT NCT00003428

    Hormone Therapy in Treating Women With Breast Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 114 participants Est. completion 2001-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00003626

    Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy

    Not yet reported Barbara Ann Karmanos Cancer Institute Est. completion 2000-05 3 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00003645

    Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence

    Not yet reported M.D. Anderson Cancer Center 64 participants Est. completion 2017-03-20 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00003653

    Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer

    Not yet reported NCIC Clinical Trials Group 1386 participants Est. completion 2013-01-10 29 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00003670

    Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer

    Not yet reported Eli Lilly and Company Est. completion 2001-01 4 sites
    Other conditions: Ovarian Cancer, Primary Peritoneal Cavity Cancer
    View official trial listing →
  • Completed NCT NCT00004054

    Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer

    Not yet reported Radiation Therapy Oncology Group 397 participants Est. completion 2013-11 54 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00004635

    Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer

    Not yet reported National Cancer Institute (NCI) 159 participants Est. completion 2010-03-30 9 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005627

    Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Dana-Farber Cancer Institute Est. completion 2003-04 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005805

    St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00005810

    Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Alliance for Clinical Trials in Oncology 40 participants Est. completion 2006-06 7 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005828

    Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Alliance for Clinical Trials in Oncology 54 participants Est. completion 2008-06 16 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005847

    Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Eastern Cooperative Oncology Group 19 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00005857

    Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

    Not yet reported City of Hope Medical Center Est. completion 2002-10 4 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00006023

    Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Swiss Cancer Institute Est. completion 2001-06 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00006044

    Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy

    Not yet reported Memorial Sloan Kettering Cancer Center 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00006114

    Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported GERCOR - Multidisciplinary Oncology Cooperative Group 10 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00010231

    Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported University of Pittsburgh 22 participants Est. completion 2002-11 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00016913

    Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 34 participants Est. completion 2008-05 23 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00017576

    Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported OHSU Knight Cancer Institute 19 participants Est. completion 2006-07 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00025116

    ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported NCIC Clinical Trials Group 40 participants Est. completion 2008-09-22 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00030654

    Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

    Not yet reported Radiation Therapy Oncology Group 21 participants Est. completion 2005-02-04 78 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00034125

    Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.

    Not yet reported Eli Lilly and Company 11 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00041301

    Assessing Quality of Life of Patients With Prostate Cancer

    European Organisation for Research and Treatment of Cancer - EORTC 625 participants Est. completion 2005-11 33 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00049257

    Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

    Not yet reported Jonsson Comprehensive Cancer Center 58 participants Est. completion 2009-03 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00050011

    Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy

    Not yet reported Novartis Pharmaceuticals 602 participants Est. completion 2009-01 44 sites
    Other conditions: Breast Neoplasms, Osteoporosis
    View official trial listing →
  • Terminated NCT NCT00066807

    Premenopausal Endocrine Responsive Chemotherapy Trial

    Not yet reported ETOP IBCSG Partners Foundation 29 participants Est. completion 2006-12 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00097344

    The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

    Not yet reported Intarcia Therapeutics 842 participants Est. completion 2006-08 104 sites
    Other conditions: Breast Neoplasms, Neoplasms, Hormone-Dependent
    View official trial listing →
  • Completed NCT NCT00104715

    Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer

    Not yet reported UNICANCER 385 participants Est. completion 2015-12-15 41 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00109473

    Trial of Growth Hormone Therapy in Pediatric Crohn's Disease

    Not yet reported Children's Hospital Medical Center, Cincinnati 22 participants Est. completion 2009-08 1 site
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00116220

    Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer

    Not yet reported Dana-Farber Cancer Institute 206 participants Est. completion 2015-02 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00120497

    Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight

    Massachusetts General Hospital 12 participants Est. completion 2011-12 1 site
    Other conditions: Fetal Growth Retardation
    View official trial listing →
  • Completed NCT NCT00128843

    Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients

    Not yet reported Spanish Breast Cancer Research Group 103 participants Est. completion 2014-10 13 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00148772

    Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy

    Not yet reported Endeavor Health 29 participants Est. completion 2008-08 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00165399

    Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment

    Not yet reported Dana-Farber Cancer Institute 62 participants Est. completion 2005-12-31 5 sites
    Other conditions: Adenocarcinoma of the Prostate, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00174408

    Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age

    Not yet reported Pfizer 110 participants Est. completion 2005-02
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT00175383

    Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer

    Not yet reported University of British Columbia 100 participants Est. completion 2008-02 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00182871

    Testosterone Effects on Bone and Frailty

    Not yet reported National Institute on Aging (NIA) 140 participants Est. completion 2007-07 1 site
    Other conditions: Aging, Frailty, Osteoporosis
    View official trial listing →
  • Completed NCT NCT00188760

    Breast Study Investigating a New Light Technique to Monitor Changes in Breast Tissue Density

    University Health Network, Toronto 300 participants Est. completion 2010-09 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00191529

    Growth Hormone Treatment in Short Children Born Small for Gestational Age

    Not yet reported Eli Lilly and Company 200 participants Est. completion 2007-06 1 site
    Other conditions: Infant, Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT00193856

    RADAR Trial - Randomised Androgen Deprivation and Radiotherapy

    Not yet reported Trans Tasman Radiation Oncology Group 1071 participants Est. completion 2017-08 24 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00194792

    Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer

    Not yet reported University of Washington 28 participants Est. completion 2011-07 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    View official trial listing →
  • Completed NCT NCT00206557

    The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study

    Not yet reported The Alfred 60 participants Est. completion 2007-04 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
    View official trial listing →
  • Terminated NCT NCT00216060

    Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy

    Not yet reported Christopher Sweeney, MBBS 63 participants Est. completion 2008-03 45 sites
    Other conditions: Metastatic Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00225420

    Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer

    Not yet reported, Not yet reported UNC Lineberger Comprehensive Cancer Center 23 participants Est. completion 2012-08 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00237198

    Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment

    Not yet reported Novartis Pharmaceuticals 47 participants 24 sites
    Other conditions: Postmenopausal Women With Advanced Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT00242931

    Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy

    Not yet reported OHSU Knight Cancer Institute Est. completion 2008-03
    Other conditions: Prostate Cancer
    View official trial listing →
  • Withdrawn NCT NCT00244920

    Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer

    Not yet reported OHSU Knight Cancer Institute Est. completion 2007-06
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00246753

    Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

    Not yet reported UNC Lineberger Comprehensive Cancer Center 29 participants Est. completion 2013-05 3 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00305747

    Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy

    Not yet reported Barbara Ann Karmanos Cancer Institute 12 participants Est. completion 2010-09 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT00310180

    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)

    Not yet reported National Cancer Institute (NCI) 10273 participants Est. completion 2030-09-30 1222 sites Stand-alone
    Other conditions: Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage IIIB Breast Cancer AJCC v7
    View official trial listing →
  • Completed NCT NCT00313170

    A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg

    Not yet reported AstraZeneca 144 participants Est. completion 2019-03-13 34 sites
    Other conditions: Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00319072

    Hormone Replacement Therapy (HRT) Website Tool

    Not yet reported National Institute on Aging (NIA) 280 participants Est. completion 2005-12 1 site
    Other conditions: Communication, Menopause, Hormone Replacement Therapy
    View official trial listing →
  • Terminated NCT NCT00354432

    Soy Protein/Effexor Hormone Therapy for Prostate Cancer

    Not yet reported Wake Forest University Health Sciences 120 participants Est. completion 2010-08-01 20 sites
    Other conditions: Hot Flashes, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00362973

    PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer

    University of Washington 42 participants 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00363285

    Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer

    Not yet reported St. Bartholomew's Hospital 900 participants 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00373386

    Growth Hormone and Endothelial Function in Children

    Not yet reported Ohio State University 9 participants Est. completion 2007-12 1 site
    Other conditions: Growth Hormone Deficiency, Panhypopituitarism, Short Stature
    View official trial listing →
  • Terminated NCT NCT00388804

    External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer

    Not yet reported M.D. Anderson Cancer Center 39 participants Est. completion 2011-04 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Withdrawn NCT NCT00403182

    Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer

    Not yet reported Technical University of Munich 9 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00411853

    Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients

    Not yet reported Sheba Medical Center 60 participants Est. completion 2012-06 1 site
    Other conditions: Hormone Refractory Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00420251

    Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis

    Not yet reported Ludwig-Maximilians - University of Munich 50 participants Est. completion 2006-07 1 site
    Other conditions: Juvenile Idiopathic Arthritis, Still Disease, Juvenile-Onset
    View official trial listing →
  • Completed NCT NCT00433589

    Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 6600 participants Est. completion 2020-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00437359

    Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer

    Not yet reported Japan Breast Cancer Research Network 240 participants Est. completion 2020-05 7 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00450463

    Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer

    Not yet reported National Cancer Institute (NCI) 64 participants Est. completion 2017-06-08 3 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00452556

    The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study

    Not yet reported Nova Scotia Cancer Centre 86 participants Est. completion 2017-02 1 site
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Status unknown NCT NCT00466102

    Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases

    Not yet reported GBG Forschungs GmbH 130 participants Est. completion 2012-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00473187

    Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic Rickets

    Not yet reported University of Rostock Est. completion 2009-08 1 site
    Other conditions: Hypophosphatemic Rickets, Growth Disorders, Somatropin Therapy
    View official trial listing →
  • Terminated NCT NCT00483561

    Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy

    Not yet reported University of Nebraska 26 participants Est. completion 2010-01 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00499083

    Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)

    Not yet reported University of Nebraska 17 participants Est. completion 2010-01-28 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00525161

    Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer

    Not yet reported Suleiman Massarweh 11 participants Est. completion 2015-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00527124

    Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

    Not yet reported National Cancer Institute (NCI) 57 participants Est. completion 2013-11 4 sites
    Other conditions: Adenocarcinoma of the Prostate, Stage IV Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00535418

    Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers

    Not yet reported, Not yet reported Novartis Pharmaceuticals 35 participants
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00544167

    Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer

    Not yet reported SCRI Development Innovations, LLC 45 participants Est. completion 2011-04 8 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00547001

    Comparison of Hormonal Therapy: Mediating Hot Flashes Tapering Regimens for Mediating Hot Flashes

    Not yet reported Hartford Hospital 235 participants Est. completion 2009-11 1 site
    Other conditions: Hot Flashes, Night Sweats
    View official trial listing →
  • Completed NCT NCT00555919

    ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer

    Not yet reported Bayer 68 participants Est. completion 2011-03 28 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT00557336

    Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age

    Not yet reported Novo Nordisk A/S 160 participants Est. completion 2005-06-29 37 sites
    Other conditions: Foetal Growth Problem, Small for Gestational Age
    View official trial listing →
  • Terminated NCT NCT00570258

    Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy

    Not yet reported University of Arkansas 27 participants Est. completion 2017-12 6 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT00579072

    The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and Older

    Memorial Sloan Kettering Cancer Center 230 participants Est. completion 2027-12 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00589420

    Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy

    Not yet reported Abramson Cancer Center at Penn Medicine 18 participants Est. completion 2011-02-02 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00601900

    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer

    Not yet reported National Cancer Institute (NCI) 394 participants Est. completion 2024-01-29 522 sites
    Other conditions: Invasive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v6, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT00602043

    F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer

    Not yet reported National Cancer Institute (NCI) 20 participants Est. completion 2014-09 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT00604825

    Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)

    Not yet reported GlaxoSmithKline 356 participants Est. completion 2008-07-23 87 sites
    Other conditions: Menopausal and Female Climacteric States
    View official trial listing →
  • Completed NCT NCT00626106

    QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer

    Not yet reported NantCell, Inc. 156 participants Est. completion 2011-09-23 60 sites
    Other conditions: Breast Cancer, Breast Tumors, Metastatic Cancer
    View official trial listing →
  • Completed NCT NCT00647218

    Paclitaxel and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer

    Not yet reported Vanderbilt-Ingram Cancer Center 38 participants Est. completion 2004-11 6 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00666822

    Compliance to a Hormone Therapy Regimen in Breast Cancer

    Case Comprehensive Cancer Center 178 participants Est. completion 2015-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00667069

    Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer

    Not yet reported UNICANCER 424 participants Est. completion 2022-05-24 17 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00681122

    CARIATIDE (Compliance of ARomatase Inhibitors AssessmenT In Daily Practice Through Educational Approach)

    AstraZeneca 2600 participants Est. completion 2011-05 164 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00685009

    The Women's Health Initiative Memory Study (The WHIMS Study)

    National Heart, Lung, and Blood Institute (NHLBI) 7525 participants Est. completion 2008-03 1 site
    Other conditions: Dementia Syndromes
    View official trial listing →
  • Completed NCT NCT00687739

    Prevention of Obesity in Women Via Estradiol Regulation

    Not yet reported University of Colorado, Denver 79 participants Est. completion 2014-06 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00711061

    Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy

    Children's Mercy Hospital Kansas City 24 participants Est. completion 2009-02 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT00726661

    An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer (VIRGO)

    Genentech, Inc. 1287 participants Est. completion 2012-12
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00757393

    Growth Hormone Therapy and Bone Quality in Pediatric Osteoporosis

    Not yet reported The Hospital for Sick Children 21 participants Est. completion 2015-09 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00769548

    Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer

    Not yet reported Radiation Therapy Oncology Group 1322 participants Est. completion 2016-12
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00773695

    A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer

    Not yet reported Hoffmann-La Roche 150 participants Est. completion 2022-11-09 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00781547

    Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus

    Not yet reported Göteborg University 40 participants Est. completion 2005-05 1 site
    Metabolic syndrome Other conditions: Abdominal Obesity, Obesity
    View official trial listing →
  • Completed NCT NCT00784888

    Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy

    Pfizer 344 participants Est. completion 2011-12 16 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT00796458

    Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer

    Not yet reported A.O.U. San Giovanni Battista di Torino, Italy 200 participants 1 site
    Other conditions: Pain, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00813189

    Efficacy Study of Recombinant Growth Hormone on Muscle Function in Children Long-term Treated With Glucocorticoid

    Not yet reported Association REMEDE 30 participants Est. completion 2012-05 1 site
    Other conditions: Chronic Disease, Glucocorticoid Therapy, Response to, Growth Retardation
    View official trial listing →
  • Status unknown NCT NCT00868868

    Pedometer and Exercise Study in Prostate Cancer Patients With Hormonal Therapy

    Groupe de recherche en Urologie de la Mauricie 400 participants Est. completion 2011-09 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00887380

    STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing)

    Not yet reported Trans Tasman Radiation Oncology Group 2023 participants Est. completion 2024-12 34 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00893061

    Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer

    Not yet reported Centre Oscar Lambret 44 participants Est. completion 2014-11-26 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00895310

    Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy

    Not yet reported University of California, Davis 30 participants Est. completion 2015-05 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00929591

    SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer

    Not yet reported SWOG Cancer Research Network 1558 participants Est. completion 2010-03
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01006564

    Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate Cancer

    Not yet reported Royal Marsden NHS Foundation Trust 30 participants Est. completion 2011-06 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Withdrawn NCT NCT01013506

    Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast Cancer

    Not yet reported Vanderbilt-Ingram Cancer Center Est. completion 2009-12
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01023061

    Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer

    Not yet reported University of Washington 24 participants Est. completion 2015-09 2 sites
    Other conditions: Adenocarcinoma of the Prostate, Stage II Prostate Cancer, Stage III Prostate Cancer, Stage IV Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01023802

    The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer

    Mayo Clinic 20 participants Est. completion 2011-02 1 site
    Other conditions: Neoadjuvant Therapy, Chemotherapy, Hormone Replacement Therapy, Breast Cancer
    View official trial listing →
  • Completed NCT NCT01025349

    Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast Cancer

    Not yet reported Taipei Medical University Hospital 20 participants Est. completion 2009-09 1 site Stand-alone
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01065220

    Sex Steroids and the Serotonin Transporter

    Not yet reported Medical University of Vienna 32 participants Est. completion 2014-01 1 site
    Other conditions: Transsexualism
    View official trial listing →
  • Completed NCT NCT01066052

    Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years

    Not yet reported Merck KGaA, Darmstadt, Germany 115 participants Est. completion 2010-08-31 1 site
    Other conditions: Turner's Syndrome
    View official trial listing →
  • Completed NCT NCT01070485

    BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant Disease

    Not yet reported Bayer 23 participants Est. completion 2012-01 4 sites
    Other conditions: Breast Cancer, Bone Metastases
    View official trial listing →
  • Status unknown NCT NCT01072318

    Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of Toremifene

    Not yet reported Korean Breast Cancer Study Group 495 participants Est. completion 2014-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01076335

    Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer

    Not yet reported M.D. Anderson Cancer Center 40 participants Est. completion 2015-06 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01129336

    Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients

    Not yet reported Novartis Pharmaceuticals 44 participants Est. completion 2012-08 33 sites Stand-alone
    Other conditions: First or Second Line HER2-negative Breast Cancer, Metastatic Disease Without Bone Metastasis
    View official trial listing →
  • Terminated NCT NCT01151215

    Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

    Not yet reported AstraZeneca 482 participants Est. completion 2013-01 60 sites
    Other conditions: Neoplasms, Breast Neoplasms, Breast Cancer
    View official trial listing →
  • Completed NCT NCT01194271

    Neoadjuvant Ipilimumab in Prostate Cancer

    Not yet reported M.D. Anderson Cancer Center 19 participants Est. completion 2015-10 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT01239251

    GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy

    Memorial Sloan Kettering Cancer Center 8 participants Est. completion 2011-11 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT01240928

    MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast Cancer

    Not yet reported Vanderbilt-Ingram Cancer Center
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01246427

    Evaluation of Homeopathic Treatment for Hot Flashes in Non Metastatic Breast Cancer

    Not yet reported Centre Leon Berard 138 participants Est. completion 2014-11 9 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01259778

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in South Korea

    Merck KGaA, Darmstadt, Germany 224 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01263717

    Effects of Growth Hormone Releasing Hormone in HIV

    Not yet reported Massachusetts General Hospital 54 participants Est. completion 2014-02 1 site
    Other conditions: HIV, HIV Lipodystrophy
    View official trial listing →
  • Completed NCT NCT01267526

    A Canadian, Multi-centre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Pediatric Subjects Using SAIZEN® Via Easypod™ Auto-injector for Growth Hormone Treatment

    Merck KGaA, Darmstadt, Germany 205 participants Est. completion 2015-12-31 9 sites
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01281137

    Study of Changes in Estrogen Levels and Grip Strength in Postmenopausal Women Who Have Received 4 to 6 Years of Hormone Therapy for Breast Cancer and Are Currently Receiving Letrozole on Clinical Trial IBCSG-35-07

    ETOP IBCSG Partners Foundation 104 participants Est. completion 2019-05-15 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01292785

    Effects of Sex Steroid Hormones on Human Brain Function, Structure and Connectivity

    Medical University of Vienna 80 participants Est. completion 2015-04 1 site
    Other conditions: Gender Identity Disorder
    View official trial listing →
  • Terminated NCT NCT01296555

    A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer

    Not yet reported Genentech, Inc. 674 participants Est. completion 2021-06-25 31 sites
    Other conditions: Solid Cancers, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT01302652

    Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly Treatment

    Massachusetts General Hospital 20 participants Est. completion 2015-02 1 site
    Other conditions: Acromegaly
    View official trial listing →
  • Completed NCT NCT01307059

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Sweden

    Merck KGaA, Darmstadt, Germany 152 participants Est. completion 2015-12-31 3 sites
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01309672

    S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy

    Not yet reported SWOG Cancer Research Network 41 participants Est. completion 2024-04-11 205 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Withdrawn NCT NCT01320046

    Vulvar Contact Dermatitis Resulting From Urine Incontinence

    Meir Medical Center Est. completion 2012-03 1 site
    Other conditions: Urinary Incontinence, Vulvar Pruritus, Vulvar Contact Dermatitis
    View official trial listing →
  • Active, not recruiting NCT NCT01327781

    Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer

    Not yet reported National Cancer Institute (NCI) 62 participants Est. completion 2026-10-30 3 sites
    Other conditions: HER2/Neu Positive, Recurrent Breast Carcinoma, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT01329757

    Efficacy and Safety of Growth Hormone Treatment in Spinal Cord Injury

    Not yet reported Hospital Nacional de Parapléjicos de Toledo 76 participants Est. completion 2015-11 1 site
    Other conditions: Spinal Cord Injury
    View official trial listing →
  • Withdrawn NCT NCT01350180

    Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis

    Dr. Tamim Niazi Est. completion 2022-12-01 8 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT01351844

    The CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer

    Not yet reported George Washington University 12 participants Est. completion 2013-05 1 site
    Other conditions: Breast Cancer, Arthralgia
    View official trial listing →
  • Completed NCT NCT01385280

    Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer

    Not yet reported University of Arizona 13 participants Est. completion 2013-10 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Terminated NCT NCT01392586

    Systemic Therapy With or Without Upfront Surgery in Metastatic Breast Cancer

    Not yet reported Jeroen Bosch Ziekenhuis 10 participants Est. completion 2014-01 26 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01400984

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Slovakia

    Merck KGaA, Darmstadt, Germany 92 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01420250

    Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 20 participants Est. completion 2020-07-21 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01421589

    Growth Hormone Treatment on Phosphocreatine Recovery in Obesity

    Not yet reported Massachusetts General Hospital 15 participants Est. completion 2013-03 1 site
    Other conditions: Obese, Growth Hormone Secretion Abnormality
    View official trial listing →
  • Completed NCT NCT01423890

    A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer

    Not yet reported Ontario Clinical Oncology Group (OCOG) 1011 participants Est. completion 2014-02 35 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01471288

    Effect of Carum Carvi on Thyroid Hormones and TSH Level

    Not yet reported, Not yet reported Mashhad University of Medical Sciences 40 participants 1 site
    Other conditions: Thyroid Cancer Patients
    View official trial listing →
  • Terminated NCT NCT01491854

    Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age

    Not yet reported Sandoz 130 participants Est. completion 2018-10-31 23 sites
    Other conditions: Short Children Born Small for Gestational Age (SGA)
    View official trial listing →
  • Completed NCT NCT01555528

    To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Mexico

    Merck KGaA, Darmstadt, Germany 193 participants Est. completion 2015-12-31 1 site
    Other conditions: Growth Disorders
    View official trial listing →
  • Completed NCT NCT01580605

    French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin

    Novo Nordisk A/S 331 participants Est. completion 2011-11-28 1 site
    Other conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT01602380

    A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.

    Not yet reported AstraZeneca 462 participants Est. completion 2026-01-16 118 sites
    Other conditions: Hormone Receptor Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT01613131

    Mirena and Estrogen for Control of Perimenopause Symptoms and Ovulation Suppression

    Not yet reported University of Colorado, Denver 39 participants Est. completion 2014-06 1 site
    Other conditions: Menopausal and Other Perimenopausal Disorders
    View official trial listing →
  • Withdrawn NCT NCT01614171

    Growth Hormone for Osteoporosis Pseudoglioma Syndrome

    Not yet reported University of Maryland, Baltimore Est. completion 2015-12 1 site
    Other conditions: Osteoporosis Pseudoglioma Syndrome
    View official trial listing →
  • Completed NCT NCT01615120

    Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer

    Not yet reported GTx 77 participants Est. completion 2016-11-09 26 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01630590

    Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer

    Not yet reported M.D. Anderson Cancer Center 62 participants Est. completion 2021-04-06 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01697644

    Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation

    Not yet reported Novo Nordisk A/S 75 participants Est. completion 2005-05 2 sites
    Other conditions: Foetal Growth Problem, Small for Gestational Age
    View official trial listing →
  • Completed NCT NCT01720602

    Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy

    Not yet reported University of Washington 15 participants Est. completion 2020-01 1 site
    Other conditions: Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT01736163

    A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 Tumours

    Genzyme, a Sanofi Company 144 participants Est. completion 2012-08 9 sites
    Other conditions: Thyroid Cancer
    View official trial listing →
  • Withdrawn NCT NCT01738685

    Intervention to Improve Self-Care of Symptoms in Breast Cancer Survivors on Adjuvant Endocrine Therapy

    Not yet reported University of Pittsburgh Est. completion 2015-12 1 site
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Status unknown NCT NCT01741883

    Side Effect Prevention Training (SEPT) for Nocebo Effects in Breast Cancer Patients

    Not yet reported Philipps University Marburg 165 participants Est. completion 2020-08 1 site
    Other conditions: Female Breast Cancer
    View official trial listing →
  • Completed NCT NCT01745965

    A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol.

    Not yet reported Women's Cancer Study Group GmbH 380 participants Est. completion 2025-01-15 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01753297

    A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.

    Not yet reported Ipsen 226 participants Est. completion 2019-09-09 18 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT01758146

    Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

    Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 412 participants Est. completion 2020-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT01773551

    Development of a Quantitative Tissue Optical Index of Breast Density For Prediction of Hormone Therapy Response

    University of California, Irvine Est. completion 2018-04 4 sites
    Other conditions: Accessory; Breast Tissue
    View official trial listing →
  • Completed NCT NCT01822288

    The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder

    Not yet reported Far Eastern Memorial Hospital 125 participants Est. completion 2021-08-26 1 site
    Other conditions: Menopausal Syndromes
    View official trial listing →
  • Completed NCT NCT01831076

    Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors

    Not yet reported University of Colorado, Denver 36 participants Est. completion 2022-01-06 1 site
    Other conditions: Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer
    View official trial listing →
  • Completed NCT NCT01896050

    Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer

    University of Michigan Rogel Cancer Center 115 participants Est. completion 2014-08 1 site
    Other conditions: Breast Cancer, Arthralgia, Obesity
    View official trial listing →
  • Terminated NCT NCT01897441

    Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer

    Not yet reported Albert Einstein College of Medicine 31 participants Est. completion 2023-10-25 1 site
    Other conditions: Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT01963481

    Exemestane and Cyclophosphamide for Metastatic Breast Cancer

    Not yet reported NYU Langone Health 23 participants Est. completion 2017-10-01 1 site
    Other conditions: Metastatic Beast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT01994239

    Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy

    Not yet reported UNICANCER 120 participants Est. completion 2025-03 39 sites Stand-alone
    Other conditions: Adenocarcinoma of Prostate
    View official trial listing →
  • Completed NCT NCT01996046

    FDG PET/CT in Breast Cancer Bone Mets

    University of Pennsylvania 26 participants Est. completion 2026-07-31 1 site
    Other conditions: Estrogen Receptor Positive Breast Cancer, Bone Metastases
    View official trial listing →
  • Terminated NCT NCT02000596

    1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.

    Not yet reported University of Maryland, Baltimore 2 participants Est. completion 2016-01 1 site Stand-alone
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02015559

    Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus

    Not yet reported Jonsson Comprehensive Cancer Center 61 participants Est. completion 2018-11-30 1 site
    Other conditions: Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Oral Complications, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    View official trial listing →
  • Completed NCT NCT02035813

    DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).

    Not yet reported Prof. Wolfgang Janni 116 participants Est. completion 2024-01-10 1 site
    Other conditions: HER2-negative and Hormone-receptor Positive Metastatic Breast Cancer, HER2-negative Circulating Tumor Cells, Postmenopausal Female Patients
    View official trial listing →
  • Completed NCT NCT02064582

    Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer

    Not yet reported University of Texas Southwestern Medical Center 7 participants Est. completion 2018-06-09 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT02089854

    Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer

    Not yet reported Peking Union Medical College Hospital 800 participants 1 site
    Other conditions: Female Breast Cancer
    View official trial listing →
  • Completed NCT NCT02107391

    Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer

    Not yet reported SOTIO a.s. 63 participants Est. completion 2016-06 9 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02122198

    Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women

    Not yet reported University of Colorado, Denver 17 participants Est. completion 2017-09-15 2 sites
    Cardiovascular disease Other conditions: Cognitive Impairment, Executive Dysfunction, Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT02132949

    A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer

    Not yet reported Hoffmann-La Roche 401 participants Est. completion 2020-08-25 80 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02137083

    A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer

    Not yet reported Fudan University 22 participants Est. completion 2017-07 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02141659

    A Study of TAK-385 in Hormone Treatment-naïve Participants With Prostate Cancer

    Not yet reported Takeda 43 participants Est. completion 2017-04-20 6 sites
    Other conditions: Hormone Treatment-naïve Participants With Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT02213991

    Intraoperative Radiotherapy for Korean Patients With Breast Cancer

    Not yet reported Gangnam Severance Hospital 215 participants Est. completion 2020-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02221999

    Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients

    Not yet reported, Not yet reported RenJi Hospital 250 participants Est. completion 2029-01 12 sites
    Other conditions: Tubular Breast Cancer, Mucinous Breast Cancer, Invasive Ductal Breast Cancer, Inflammatory Breast Cancer
    View official trial listing →
  • Completed NCT NCT02228681

    Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer

    Not yet reported GOG Foundation 74 participants Est. completion 2024-08-22 26 sites
    Other conditions: Advanced, Persistent, or Recurrent Endometrial Cancer
    View official trial listing →
  • Terminated NCT NCT02258464

    Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer

    Not yet reported Bayer 99 participants Est. completion 2019-08-13 71 sites Stand-alone
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Status unknown NCT NCT02264743

    Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy

    Not yet reported Royal Brompton & Harefield NHS Foundation Trust 60 participants Est. completion 2015-11 3 sites
    Other conditions: Venous Thrombosis, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT02269982

    Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY

    Duke University 120 participants Est. completion 2019-04-30 5 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT02284581

    Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments

    Consorzio Oncotech 10000 participants Est. completion 2025-12 35 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02308020

    A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain

    Not yet reported Eli Lilly and Company 162 participants Est. completion 2019-11-08 44 sites
    Other conditions: Breast Cancer, Non-small Cell Lung Cancer, Melanoma, Brain Metastases
    View official trial listing →
  • Active, not recruiting NCT NCT02308085

    Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer

    Not yet reported ETOP IBCSG Partners Foundation 518 participants Est. completion 2028-12 211 sites
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02338310

    Trial of Perioperative Endocrine Therapy - Individualising Care

    Not yet reported Institute of Cancer Research, United Kingdom 4486 participants Est. completion 2034-04 128 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02347449

    The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population

    Not yet reported Sunnybrook Health Sciences Centre 100 participants Est. completion 2016-09-30 1 site
    Other conditions: Hormone Receptor Positive Malignant Neoplasm of Breast
    View official trial listing →
  • Active, not recruiting NCT NCT02352883

    MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ

    Not yet reported ECOG-ACRIN Cancer Research Group 368 participants Est. completion 2027-11 76 sites
    Other conditions: Ductal Breast Carcinoma In Situ
    View official trial listing →
  • Completed NCT NCT02366494

    Micro RNAs to Predict Response to Androgen Deprivation Therapy

    Medical College of Wisconsin 42 participants Est. completion 2021-05-11 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02398773

    FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy

    Not yet reported National Cancer Institute (NCI) 99 participants Est. completion 2026-12-31 25 sites
    Other conditions: HER2/Neu Negative, Progesterone Receptor Negative, Progesterone Receptor Positive, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT02400060

    Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer

    Not yet reported Ohio State University Comprehensive Cancer Center 39 participants Est. completion 2020-06-30 4 sites
    Other conditions: Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage 0 Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02408536

    Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer

    National Cancer Institute, Naples 150 participants Est. completion 2024-07 1 site
    Other conditions: Low-grade Serous Ovarian Carcinoma, Recurrent Invasive Borderline Serous Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT02440230

    Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients

    Not yet reported Shanghai Jiao Tong University School of Medicine 110 participants Est. completion 2021-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02492607

    Management of Low-risk (Grade I and II) DCIS

    Not yet reported The Netherlands Cancer Institute 2500 participants Est. completion 2034-02-01 60 sites
    Other conditions: DCIS
    View official trial listing →
  • Active, not recruiting NCT NCT02530177

    Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer

    Memorial Sloan Kettering Cancer Center 546 participants Est. completion 2026-08 1 site
    Other conditions: Non-Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02532400

    Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients

    Not yet reported Ruijin Hospital 21 participants Est. completion 2019-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02549430

    To Reverse ENDocrine Resistance Trial - PD 0332991 Monotherapy vs PD 0332991 in Combination With the Endocrine Therapy

    Not yet reported Fondazione Sandro Pitigliani 115 participants Est. completion 2017-02-09 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02549729

    Effect of the Pelvic Floor Training in Postmenopausal Women With or Without Hormonal Therapy

    Not yet reported University of Sao Paulo 88 participants Est. completion 2016-08 1 site
    Other conditions: Weak; Pelvic Floor, Weak; Muscle, Urinary Incontinence
    View official trial listing →
  • Terminated NCT NCT02580045

    Pharmacokinetics of Systemic Anti-Cancer Therapies in the Cerebrospinal Fluid (CSF) of Patients With Advanced Cancer

    Duke University 3 participants Est. completion 2018-02-22 1 site
    Other conditions: Metastatic Cancer Patients on an Anti-cancer Therapy, Advanced Cancer, Brain Metastasis
    View official trial listing →
  • Status unknown NCT NCT02597868

    A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)

    Not yet reported Zhejiang Cancer Hospital 132 participants Est. completion 2017-07 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02598310

    Neoadjuvant Nab-PTX and Trastuzumab for ER Negative and HER2 Positive Breast Cancer

    Not yet reported Osaka Medical College 30 participants Est. completion 2018-11-30 1 site
    Other conditions: Breast Cancer, Estrogen Receptor Negative Neoplasm, HER-2 Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02616562

    Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency

    Not yet reported Novo Nordisk A/S 76 participants Est. completion 2024-09-26 89 sites
    Other conditions: Growth Hormone Disorder, Growth Hormone Deficiency in Children
    View official trial listing →
  • Status unknown NCT NCT02617108

    Intrauterine Balloon and Postoperative Estrogen Therapy in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis

    Not yet reported Fu Xing Hospital, Capital Medical University 310 participants Est. completion 2021-11 Stand-alone
    Other conditions: Uterine Septum
    View official trial listing →
  • Active, not recruiting NCT NCT02623972

    A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer

    Not yet reported Dana-Farber Cancer Institute 22 participants Est. completion 2026-12 2 sites
    Other conditions: Inflammatory Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
    View official trial listing →
  • Status unknown NCT NCT02651896

    Hypofractionated Intensity Modulated and Image Guided Radiotherapy for Localized Prostate Cancer

    Hospital Sirio-Libanes 130 participants Est. completion 2019-12 2 sites
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT02685397

    Management of Castration-Resistant Prostate Cancer with Oligometastases

    Not yet reported, Not yet reported Sir Mortimer B. Davis - Jewish General Hospital 102 participants Est. completion 2041-08 11 sites
    Other conditions: Castration-resistant Prostate Cancer Patients with Oligometastases
    View official trial listing →
  • Status unknown NCT NCT02690480

    Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancer

    Not yet reported Spanish Breast Cancer Research Group 189 participants Est. completion 2023-12 32 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Terminated NCT NCT02693002

    Estrogen Diastolic Heart Failure

    Not yet reported Gretchen Wells 4 participants Est. completion 2016-11 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT02720770

    Growth Hormone Treatment in Children With Hypophosphatemic Rickets

    Not yet reported, Not yet reported Bicetre Hospital 19 participants Est. completion 2011-01
    Other conditions: X Linked Hypophosphatemic Rickets
    View official trial listing →
  • Completed NCT NCT02753686

    Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy

    Novartis Pharmaceuticals 440 participants Est. completion 2022-12-01 25 sites
    Other conditions: HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT02758756

    Pilot Study on Energy Therapy or Massage to Reduce Fatigue

    Not yet reported University of Rochester 87 participants Est. completion 2019-05 1 site
    Other conditions: Fatigue
    View official trial listing →
  • Completed NCT NCT02785861

    Step by Step After Cancer

    Not yet reported Centre Hospitalier Universitaire, Amiens 17 participants Est. completion 2026-02-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02791750

    5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma

    Institut de Cancérologie de Lorraine 150 participants Est. completion 2017-06-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02823262

    A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older

    Not yet reported Beth Israel Deaconess Medical Center 65 participants Est. completion 2022-03 2 sites
    Other conditions: Breast Cancer, Estrogen Receptor Positive Breast Cancer, Node-negative Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
    View official trial listing →
  • Completed NCT NCT02841137

    Efficacy Study of Progesterone Tablet in Post-menopausal Women

    Not yet reported IBSA Institut Biochimique SA 80 participants Est. completion 2018-04-25 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT02878057

    Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer(CABC006)

    Not yet reported Peking University Cancer Hospital & Institute 30 participants Est. completion 2020-09-02
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02894398

    Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant

    Not yet reported iOMEDICO AG 388 participants Est. completion 2023-02-15 70 sites
    Other conditions: Breast Cancer, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
    View official trial listing →
  • Status unknown NCT NCT02896504

    Chemotherapy Effect on Brain Structure, Neurophysiology and Psychomotor Behavior in Breast Cancer Patients

    Kessler Foundation 60 participants Est. completion 2018-09 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02913859

    Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer

    Not yet reported University Hospital Sestre Milosrdnice 60 participants Est. completion 2020-12 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02941926

    Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC

    Not yet reported Novartis Pharmaceuticals 3246 participants Est. completion 2022-11-09 495 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02947685

    Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer

    Not yet reported Alliance Foundation Trials, LLC. 518 participants Est. completion 2030-12-31 108 sites
    Other conditions: HER-2 Positive Breast Cancer, Estrogen Receptor Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT02997995

    Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant Exposure

    Not yet reported UNICANCER 61 participants Est. completion 2020-08-28 29 sites
    Other conditions: Breast Cancer, Estrogen Receptor Positive Tumor, Menopause, Hormone Antagonist
    View official trial listing →
  • Active, not recruiting NCT NCT03016741

    Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

    Not yet reported Northwestern University 100 participants Est. completion 2029-08 5 sites
    Other conditions: Castration-Resistant Prostatic Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer, Hormone-Refractory Prostate Cancer
    View official trial listing →
  • Completed NCT NCT03033121

    Three-times-weekly Versus Daily Growth Hormone (GH) Treatment in naïve GH-deficient Children

    Not yet reported University of Palermo 32 participants Est. completion 2017-01-01 1 site
    Other conditions: Growth Hormone Treatment
    View official trial listing →
  • Withdrawn NCT NCT03058939

    Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer

    Not yet reported University of Chicago Est. completion 2019-06 1 site
    Other conditions: Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III
    View official trial listing →
  • Completed NCT NCT03176238

    Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer

    Not yet reported Novartis Pharmaceuticals 235 participants Est. completion 2019-01-29 55 sites
    Other conditions: Post Menopausal Breast Cancer
    View official trial listing →
  • Completed NCT NCT03184090

    Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC

    Not yet reported MedSIR 33 participants Est. completion 2020-10-27 15 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03186599

    Analysis of Initial Adherence and Its Impact on Long-term Adherence to Hormonal Therapy for Breast Cancer

    Not yet reported Gachon University 200 participants Est. completion 2018-10-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03195192

    Utilizing Multiomic Advanced Diagnostics to Identify CDK 4/6 Inhibitor Response Predictors and a Post-treatment Multiomic Signature for Patients With ER+/HER2- Metastatic Breast Cancer

    Not yet reported Side-Out Foundation 28 participants Est. completion 2020-06-30 8 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03204734

    Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer

    Not yet reported Zhejiang Cancer Hospital 132 participants Est. completion 2021-12-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03213925

    Neoadjuvant Chemotherapy Followed by Radiotherapy Alone in Patients With Breast Cancer

    Not yet reported Instituto do Cancer do Estado de São Paulo 1 participants Est. completion 2025-07-01 1 site
    Other conditions: Breast Cancer, Radiation Therapy
    View official trial listing →
  • Completed NCT NCT03227328

    CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDO

    Not yet reported Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 52 participants Est. completion 2022-07-01 20 sites
    Other conditions: Hormone Receptor Positive Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT03259711

    Comparison of Cardiotoxicity Induced by Selective Estrogen REceptor Modulators and aNti-Aromatase

    Groupe Hospitalier Pitie-Salpetriere 20000 participants Est. completion 2017-08-14 1 site
    Other conditions: Cardiac Affections
    View official trial listing →
  • Completed NCT NCT03270969

    A Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender Women

    Not yet reported University of Nebraska 15 participants Est. completion 2018-09-10 1 site
    Other conditions: HIV Prevention
    View official trial listing →
  • Active, not recruiting NCT NCT03281902

    Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy

    Mayo Clinic 68 participants Est. completion 2028-03-04 3 sites
    Other conditions: Advanced Breast Carcinoma, Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Status unknown NCT NCT03327207

    Exploring Interactions Between Growth Hormone and the Microbiome

    Rambam Health Care Campus 200 participants Est. completion 2021-11 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT03355157

    A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study).

    Not yet reported GBG Forschungs GmbH 130 participants Est. completion 2024-08-30 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03425838

    Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

    Not yet reported Borstkanker Onderzoek Groep 1050 participants Est. completion 2028-12 72 sites
    Other conditions: Breast Neoplasm Female
    View official trial listing →
  • Active, not recruiting NCT NCT03439735

    Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for HR+ MBC

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 45 participants Est. completion 2027-11-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03458559

    Rhenium-188-HEDP vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal Therapy

    Not yet reported Amsterdam UMC, location VUmc 402 participants Est. completion 2024-05-16 1 site
    Other conditions: Prostate Cancer Metastatic to Bone
    View official trial listing →
  • Completed NCT NCT03523572

    Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer

    Not yet reported Daiichi Sankyo 86 participants Est. completion 2023-09-12 29 sites Stand-alone
    Other conditions: Breast Cancer, Urothelial Carcinoma
    View official trial listing →
  • Status unknown NCT NCT03549663

    Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN)

    Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 108 participants Est. completion 2021-10 1 site
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Status unknown NCT NCT03556800

    Study to Investigate the Pharmacokinetics & Safety Following One Application of 3 Different Doses 0.5,0.75,& 1.25 gm,a Transdermal Estradiol Cream (VML-0203), in Comparison to a Single Dose of EstroGel 1.25 gm to Healthy Post-menopausal Women.

    Not yet reported Viramal Limited 20 participants Est. completion 2022-06-30 1 site
    Other conditions: Menopause
    View official trial listing →
  • Completed NCT NCT03556904

    FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)

    Not yet reported University of Michigan Rogel Cancer Center 14 participants Est. completion 2023-07-28 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT03568149

    Pelvic Congestion Syndrome and Endometriosis

    IRCCS Azienda Ospedaliero-Universitaria di Bologna 160 participants Est. completion 2019-08 1 site
    Other conditions: Pelvic Congestive Syndrome, Endometriosis
    View official trial listing →
  • Completed NCT NCT03579680

    De-implementation of Low Value Castration for Men With Prostate Cancer

    Not yet reported University of Michigan 60 participants Est. completion 2023-04-06 1 site
    Other conditions: Cancer of Prostate
    View official trial listing →
  • Completed NCT NCT03620734

    Study to Determine Interaction Between the Use of Feminizing Hormone Therapy and Antiretroviral Agents Concomitantly Among Transgender Women

    Thai Red Cross AIDS Research Centre 40 participants Est. completion 2019-10-01 1 site
    Other conditions: PrEP and ART
    View official trial listing →
  • Terminated NCT NCT03636776

    Quality of Life and Psychological Vulnerability in Patients With RH+ Metastatic Breast Cancer

    Not yet reported Institut Cancerologie de l'Ouest 60 participants Est. completion 2022-01-11 2 sites
    Other conditions: Metastatic Breast Cancer, Positive Hormonal Receptors
    View official trial listing →
  • Completed NCT NCT03672396

    Home-based Exercise Intervention for Patients With Metastatic Prostate Cancer

    Not yet reported UNC Lineberger Comprehensive Cancer Center 22 participants Est. completion 2019-12-31 2 sites
    Other conditions: Castration-resistant Prostate Cancer, Androgen Deprivation Therapy
    View official trial listing →
  • Completed NCT NCT03685331

    HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer

    Not yet reported Abramson Cancer Center at Penn Medicine 9 participants Est. completion 2025-12-01 1 site
    Other conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer, Advanced Breast Cancer, BRCA2 Mutation, BRCA1 Mutation
    View official trial listing →
  • Completed NCT NCT03695341

    500mg Fulvestrant Versus Everolimus Plus Exemestane in MBC Patients Refractory to Previous AI

    Fudan University 130 participants Est. completion 2019-05-15 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03701334

    A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer

    Not yet reported Novartis Pharmaceuticals 5101 participants Est. completion 2030-05-29 387 sites
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Completed NCT NCT03719495

    Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer

    Duke University 68 participants Est. completion 2023-07-31 1 site
    Other conditions: Breast Cancer, Estrogen Receptor-positive Breast Cancer, Healthy
    View official trial listing →
  • Active, not recruiting NCT NCT03725059

    Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

    Not yet reported Merck Sharp & Dohme LLC 1240 participants Est. completion 2031-01-24 244 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03776045

    PROState Cancer Patients Initiating Hormone Therapy: Effect of Exercise on CARDIOvascular Health (PROSCARDIO)

    Not yet reported University of East Anglia 50 participants Est. completion 2016-02-03
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT03786575

    Clinical Value of Next Generation Sequencing in Endocrine Therapy for Advanced Hormone Receptor Positive/HER-2 Negative Breast Cancer

    Not yet reported Peking Union Medical College 50 participants Est. completion 2021-12-31 1 site
    Other conditions: Breast Neoplasm Female, Therapeutics, Mutation
    View official trial listing →
  • Completed NCT NCT03809988

    PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)

    Not yet reported MedSIR 198 participants Est. completion 2022-11-30 53 sites
    Other conditions: Breast Cancer, Advanced Breast Cancer, Hormone Receptor Positive Tumor, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
    View official trial listing →
  • Status unknown NCT NCT03864250

    Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy

    Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 124 participants Est. completion 2021-11 1 site
    Other conditions: Tacrolimus, Idiopathic Membranous Nephropathy, Clinical Trial
    View official trial listing →
  • Status unknown NCT NCT03873428

    Evaluation of the Unconformity of the Hormonal Status of Metastatic Lesions During a First Relapse of Breast Cancer Initially Expressing Estrogen Receptors: a Pilot Study on the Interest of PET With FES

    Not yet reported Centre Georges Francois Leclerc 25 participants Est. completion 2025-10-18 2 sites
    Other conditions: FES TEP in Detection of Estrogen Receptors
    View official trial listing →
  • Active, not recruiting NCT NCT03900637

    PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate

    Not yet reported Seoul National University Hospital 122 participants Est. completion 2028-12-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT03906669

    A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer.

    Not yet reported St Vincent's Hospital 200 participants Est. completion 2024-04 1 site
    Other conditions: Early-stage Breast Cancer, Hormone Receptor Positive Tumor
    View official trial listing →
  • Active, not recruiting NCT NCT03917082

    Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer

    Not yet reported British Columbia Cancer Agency 290 participants Est. completion 2029-05-01 1 site
    Other conditions: Breast Cancer Female, Hormone Receptor Positive Tumor
    View official trial listing →
  • Completed NCT NCT03948568

    Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)

    Not yet reported Ottawa Hospital Research Institute 262 participants Est. completion 2022-04-09 1 site
    Other conditions: Early-stage Breast Cancer
    View official trial listing →
  • Enrolling by invitation NCT NCT03972345

    Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)

    Novo Nordisk A/S 750 participants Est. completion 2031-06-30 1 site
    Other conditions: Growth Hormone Deficiency in Children, Born Small for Gestational Age
    View official trial listing →
  • Status unknown NCT NCT04012918

    Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled Study

    Not yet reported Ain Shams University 124 participants Est. completion 2021-02 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04071236

    Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy

    Not yet reported, Not yet reported National Cancer Institute (NCI) 90 participants Est. completion 2027-04-30 32 sites
    Other conditions: Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lymph Nodes, Stage IVB Prostate Cancer AJCC v8
    View official trial listing →
  • Completed NCT NCT04097756

    A Phase I Study of LX-039 Tablets

    Not yet reported Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. 44 participants Est. completion 2023-02-07 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT04109066

    Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer

    Not yet reported Bristol-Myers Squibb 521 participants Est. completion 2023-12-27 240 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04128488

    Effects of Gender-Affirming Hormone Therapy Among Transgender Women

    Massachusetts General Hospital 33 participants Est. completion 2024-03-28 1 site
    Cardiovascular disease Other conditions: Transgender Women, HIV/AIDS, Metabolic Disease, Coagulopathy
    View official trial listing →
  • Status unknown NCT NCT04152057

    Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast Cancer

    Not yet reported, Not yet reported West China Hospital 20 participants Est. completion 2021-04 1 site
    Other conditions: Breast Cancer, HER2 Positive, Combination Chemotherapy
    View official trial listing →
  • Status unknown NCT NCT04188275

    CIRCULATING MICRO-RNA (miRNA) AND AR-V7 MUTATIONAL STATUS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): PRIMERA+ STUDY (PROSTATE CANCER INNOVATING MARKERS OF EXPECTED RESPONSE TO AGONIST LHRH+ ANDROGEN RECEPTOR INHIBITION

    Azienda Ospedaliero-Universitaria Careggi 46 participants Est. completion 2022-06-30 1 site
    Other conditions: D011471, D064129, D035683, D009360, D014408
    View official trial listing →
  • Completed NCT NCT04200001

    Evaluation of Sexual Quality of Life for Breast Cancer

    Institut du Cancer de Montpellier - Val d'Aurelle 45 participants Est. completion 2020-07-31 1 site
    Other conditions: Breast Cancer, Cancer, Quality of Life
    View official trial listing →
  • Status unknown NCT NCT04220398

    Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate Cancer

    Not yet reported RenJi Hospital 475 participants Est. completion 2024-12-31
    Other conditions: Prostate Cancer, Chemotherapy Effect, Hormone Sensitive Prostate Cancer, Locally Advanced Prostate Carcinoma
    View official trial listing →
  • Completed NCT NCT04237467

    Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Men

    University of Colorado, Denver 16 participants Est. completion 2023-12-31 1 site
    Other conditions: Transgender, Gender Identity, Vascular Stiffness, Vascular Inflammation, Blood Pressure, Lipid Disorder, Appetitive Behavior
    View official trial listing →
  • Completed NCT NCT04276272

    D4 Choline Breast PET/CT

    Imperial College London 6 participants Est. completion 2023-11-03 1 site
    Other conditions: HER2-negative Breast Cancer, ER Positive Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04282031

    A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer

    Not yet reported, Not yet reported Beta Pharma (Suzhou) Co., Ltd. 224 participants Est. completion 2025-06-30 1 site
    Other conditions: Advanced Solid Tumor, HR+/HER2- Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT04301375

    Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti- HER2-based Neoadjuvant Therapy (ELPIS Trial)

    Not yet reported David Garcia Cinca 27 participants Est. completion 2027-07-15 1 site
    Other conditions: Mammary Cancer
    View official trial listing →
  • Completed NCT NCT04305093

    Data Mining: Precision Analytical Retrospective Data Correlation

    Precision Analytical, Inc. 144561 participants Est. completion 2023-03-28 1 site
    Other conditions: Obesity; Endocrine, Hormone Disturbance
    View official trial listing →
  • Status unknown NCT NCT04318223

    Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy

    Not yet reported Consorzio Oncotech 168 participants Est. completion 2023-07-31 19 sites
    Other conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT04340713

    The Effect of Information Support Program on Self-efficacy of Prostate Cancer Patients During Hormonal Therapy

    Not yet reported Fudan University 95 participants Est. completion 2020-02-29 1 site Stand-alone
    Other conditions: Information Support
    View official trial listing →
  • Completed NCT NCT04341324

    Effect of ADT in Chinese Male With Prostate Cancer

    Chinese University of Hong Kong 60 participants Est. completion 2019-12-04
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT04354896

    The Effect of Thyroid Hormone Therapy on Muscle Mass and Function in Older Adults With Subclinical Hypothyroidism

    Not yet reported Insel Gruppe AG, University Hospital Bern 322 participants Est. completion 2018-05-04 5 sites
    Other conditions: Subclinical Hypothyroidism, Sarcopenia
    View official trial listing →
  • Status unknown NCT NCT04355858

    Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer

    Not yet reported Fudan University 319 participants Est. completion 2025-04-01 1 site
    Other conditions: Breast Cancer, Metastatic Cancer
    View official trial listing →
  • Status unknown NCT NCT04400942

    Predictive Factors for Complete Myoma Resection During Hysteroscopic Myomectomy

    Ospedale Policlinico San Martino 600 participants Est. completion 2021-12-01 1 site
    Other conditions: Uterine Fibroids, Uterine Myomas
    View official trial listing →
  • Completed NCT NCT04424108

    Hormone Therapy on Serum Ischemia Modified Albumin in Menopausal Women

    Karadeniz Technical University 30 participants Est. completion 2010-05-20
    Other conditions: Hormone Therapy Induced Morphologic Change, Surgical Menopause
    View official trial listing →
  • Completed NCT NCT04424173

    Combined Hormone Therapy, C-reactive Protein(CRP) Levels and Life Quality in Natural Menopause Women

    Karadeniz Technical University 45 participants Est. completion 2008-08-30
    Other conditions: CRP, Menopause
    View official trial listing →
  • Completed NCT NCT04478760

    Trans & Non-binary Reference Intervals While on Hormone Therapy Study

    King's College Hospital NHS Trust 250 participants Est. completion 2024-05-14 1 site
    Other conditions: Transgender Persons, Hormone Replacement Therapy, Reference Values
    View official trial listing →
  • Completed NCT NCT04515888

    Evaluation of the Prevalence of Pelvic Static Disorders in Women With Localized Breast Cancer

    Institut du Cancer de Montpellier - Val d'Aurelle 246 participants Est. completion 2021-07-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT04524325

    Mechanisms of Blood Pressure Dysfunction in Transmen Receiving Testosterone

    Not yet reported Yale University Est. completion 2024-06-30
    Other conditions: Transgender Men, Blood Pressure, Hyperandrogenism
    View official trial listing →
  • Active, not recruiting NCT NCT04554927

    Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer

    Not yet reported Centre Francois Baclesse 438 participants Est. completion 2026-12-31 1 site
    Other conditions: Web-application, Breast Cancer, Hormono Therapy
    View official trial listing →
  • Active, not recruiting NCT NCT04565054

    Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC

    Not yet reported Women's Cancer Study Group GmbH 1260 participants Est. completion 2029-07 85 sites
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Active, not recruiting NCT NCT04584853

    PreOperative Endocrine Therapy for Individualised Care With Abemaciclib

    Not yet reported Institute of Cancer Research, United Kingdom 123 participants Est. completion 2030-10 62 sites
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Active, not recruiting NCT NCT04597580

    Personalised Disease Monitoring in Metastatic Breast Cancer

    The Christie NHS Foundation Trust 97 participants Est. completion 2030-01-31 7 sites
    Other conditions: Breast Cancer Metastatic, Estrogen Receptor-positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT04600336

    Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 88 participants Est. completion 2024-03-11 103 sites
    Other conditions: Prostate Carcinoma
    View official trial listing →
  • Status unknown NCT NCT04646564

    Radiotherapy for Extracranial Oligometastatic Breast Cancer

    Not yet reported Chinese Academy of Medical Sciences 170 participants Est. completion 2026-04-30 2 sites
    Other conditions: Breast Cancer Metastatic
    View official trial listing →
  • Status unknown NCT NCT04666805

    Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast

    First Hospital of China Medical University 1354 participants Est. completion 2021-01-15 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04733118

    Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer

    Not yet reported MedSIR 393 participants Est. completion 2028-03 41 sites
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Completed NCT NCT04736576

    Study to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine Monotherapy

    Not yet reported Pfizer 99 participants Est. completion 2023-03-24 20 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT04738292

    Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)

    Not yet reported University of Wisconsin, Madison 11 participants Est. completion 2023-05-15 2 sites
    Other conditions: ER-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04762979

    Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer

    Not yet reported Marina N Sharifi 44 participants Est. completion 2026-05 4 sites
    Other conditions: Hormone Receptor Positive Breast Carcinoma, HER2-negative Breast Cancer, PIK3CA Mutant Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT04856371

    Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer

    Not yet reported Haihe Biopharma Co., Ltd. 228 participants Est. completion 2022-12
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT04861896

    A Research Study for Latina Women With Breast Cancer

    Not yet reported Northwestern University 58 participants Est. completion 2023-11-07 1 site
    Other conditions: Cancer, Breast, Cancer-related Problem/Condition, Quality of Life, Hormone Dependent Neoplasms, Adherence, Medication
    View official trial listing →
  • Completed NCT NCT04864405

    Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance

    Not yet reported Ottawa Hospital Research Institute 245 participants Est. completion 2023-07-29 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04887701

    Non-hormonal Medical Device for Treatment of Vulvovaginal Atrophy (VVA) in Post-Menopausal Women

    Not yet reported Madorra 25 participants Est. completion 2022-08-22 3 sites
    Other conditions: Vulvovaginal Atrophy
    View official trial listing →
  • Completed NCT NCT04892914

    Embr Thermal Device for Hot Flash Management in Prostate Cancer

    Not yet reported Embr Labs, Inc. 57 participants Est. completion 2021-12-05 1 site
    Other conditions: Prostate Cancer, Hot Flashes
    View official trial listing →
  • Active, not recruiting NCT NCT04915508

    Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy

    Not yet reported Jonsson Comprehensive Cancer Center 165 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Prostate Adenocarcinoma, Stage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIIC Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Stage IVB Prostate Cancer AJCC v8
    View official trial listing →
  • Status unknown NCT NCT04922008

    Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS-C/D)

    Not yet reported Fudan University 356 participants Est. completion 2026-06-30
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04975308

    A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

    Not yet reported Eli Lilly and Company 874 participants Est. completion 2027-08 243 sites
    Other conditions: Breast Neoplasms, Neoplasm Metastasis
    View official trial listing →
  • Completed NCT NCT04981275

    A Multi-omic Approach to Evaluate and Characterize the Polycystic Ovary Syndrome (PCOS) Phenotype

    Onegevity Health 81 participants Est. completion 2023-09-30 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Status unknown NCT NCT04995731

    Risk Assessment of Endometrial Hyperplasia and Endometrial Cancer

    Assiut University 328 participants Est. completion 2024-07 1 site
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT05043506

    European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal Therapies

    Pfizer 1939 participants Est. completion 2023-11-02 64 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05100472

    A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 50 participants Est. completion 2026-10-19 7 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT05122377

    RWE About QOL and Compliance of Patients With OFS in China

    Fudan University 562 participants Est. completion 2025-05-01 1 site
    Other conditions: Breast Cancer, Quality of Life, Hormone Receptor-positive Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT05131893

    Neoadjuvant Treatment of Breast Cancer

    National Institute of Oncology, Hungary 300 participants Est. completion 2031-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05159778

    Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA)

    Not yet reported HiberCell, Inc. 26 participants Est. completion 2023-04-12 16 sites
    Other conditions: Malignant Neoplasm of Breast
    View official trial listing →
  • Status unknown NCT NCT05186545

    An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer

    Not yet reported The First Affiliated Hospital of Zhengzhou University 63 participants Est. completion 2025-07 5 sites
    Other conditions: Breast Cancer, Breast Cancer Female
    View official trial listing →
  • Terminated NCT NCT05207709

    Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype

    Not yet reported SOLTI Breast Cancer Research Group 61 participants Est. completion 2026-03-26 71 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05251714

    CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer

    Not yet reported, Not yet reported Treadwell Therapeutics, Inc 44 participants Est. completion 2026-08 4 sites
    Other conditions: Advanced Solid Tumor, Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05277935

    Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib

    Not yet reported Beneficência Portuguesa de São Paulo 68 participants Est. completion 2025-03-01 4 sites
    Other conditions: Breast Neoplasm Female, Quality of Life
    View official trial listing →
  • Not yet recruiting NCT NCT05285332

    Classified Treatment Strategy for De-novo Metastatic Breast Cancer After Systemic Adjuvant Therapy

    Not yet reported Changhai Hospital 362 participants Est. completion 2031-05-01
    Other conditions: Breast Neoplasms, Treatment, Metastatic Breast Cancer, Survival
    View official trial listing →
  • Completed NCT NCT05324020

    eHealth Intervention for Medication Adherence in Breast Cancer Survivors

    Not yet reported Luxembourg Institute of Health 3 participants Est. completion 2022-11-30 2 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05392608

    SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)

    Not yet reported Borstkanker Onderzoek Groep 130 participants Est. completion 2028-03 25 sites
    Other conditions: Neoplasm, Breast, Congenital, Familial and Genetic Disorders
    View official trial listing →
  • Status unknown NCT NCT05411380

    Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.

    Not yet reported wang shusen 73 participants Est. completion 2025-04-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05437679

    Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System

    Angle plc 9 participants Est. completion 2023-08-22 2 sites
    Other conditions: High Risk Prostate Carcinoma, Biochemically Recurrent Prostate Carcinoma, Castration-resistant Prostate Cancer, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT05483621

    Hormonal Stimulation of Spermatogenesis

    Not yet reported Egymedicalpedia 100 participants Est. completion 2022-03-01 1 site Stand-alone
    Other conditions: Azoospermia, Nonobstructive
    View official trial listing →
  • Terminated NCT NCT05488145

    A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy

    Not yet reported Emory University 21 participants Est. completion 2025-12-10 4 sites
    Other conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma, Hormone Receptor-Positive Breast Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05525481

    Tamoxifen Prediction Study in Patients With ER+ Breast Cancer

    Not yet reported Erasmus Medical Center 100 participants Est. completion 2024-02-28 1 site
    Other conditions: ER+ Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05529862

    Trans-RosaLEE Study: a Biomarker-directed, Translational Study

    Not yet reported Institut Paoli-Calmettes 115 participants Est. completion 2028-11-01 1 site
    Other conditions: Advanced or Metastatic Breast Cancer (BC)
    View official trial listing →
  • Withdrawn NCT NCT05568940

    Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids

    McGill University Health Centre/Research Institute of the McGill University Health Centre Est. completion 2026-04 1 site
    Other conditions: Endometriosis, Fibroids
    View official trial listing →
  • Active, not recruiting NCT NCT05612100

    Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients

    Mayo Clinic 169 participants Est. completion 2028-07-09 23 sites
    Other conditions: Breast Carcinoma
    View official trial listing →
  • Terminated NCT NCT05617885

    Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

    Not yet reported Praful Ravi, MB BCHir, MRCP 9 participants Est. completion 2026-06-01 1 site Stand-alone
    Other conditions: Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT05640778

    Neoadjuvant Dalpiciclib Plus Aromatase Inhibitors in Luminal B/HER2-negative Breast Cancer (DANCER)

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 30 participants Est. completion 2025-10-31 1 site
    Other conditions: Luminal B/HER2-negative Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT05643131

    Hyivy Device as Non-hormonal Therapy in Endometriosis

    Not yet reported Hyivy Health Inc 20 participants Est. completion 2026-12 1 site
    Other conditions: Endometriosis, Pelvic Pain
    View official trial listing →
  • Enrolling by invitation NCT NCT05645536

    Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

    Not yet reported Tolmar Inc. 250 participants Est. completion 2030-03 46 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05663892

    Drug-Drug Interaction Study in Trans Women Living With HIV

    Not yet reported Maple Leaf Research 45 participants Est. completion 2025-01 1 site
    Other conditions: Hiv, Transgenderism
    View official trial listing →
  • Completed NCT NCT05690295

    Resistance-type Exercise Training in Postmenopausal Women Survivors of Breast Cancer

    Not yet reported Universidad de La Frontera 26 participants Est. completion 2024-05-15 1 site
    Other conditions: Breast Cancer Survivors, Postmenopause, Resistance Training
    View official trial listing →
  • Completed NCT NCT05700006

    Pilot Observational Study Examining the Effect of Endocrine Therapy on Aging

    University of Michigan 94 participants Est. completion 2026-02-26 1 site
    Other conditions: Breast Neoplasm Female, Arthralgia, Aging
    View official trial listing →
  • Active, not recruiting NCT NCT05730647

    Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients

    Consorzio Oncotech 600 participants Est. completion 2032-07-31 40 sites
    Other conditions: Early Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05766410

    A Randomized Study Comparing the Immune Modulation Effect of Ribociclib, Palbociclib, and Abemaciclib in ER+/HER2- EBC

    Not yet reported National Taiwan University Hospital 60 participants Est. completion 2026-09-30 2 sites
    Other conditions: Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Therapy
    View official trial listing →
  • Completed NCT NCT05789771

    Abemaciclib for the Treatment of Luminal Metastatic breAst caNcer in the Real-life Clinical pracTice in Russia.

    Blokhin's Russian Cancer Research Center 136 participants Est. completion 2022-12-01 1 site
    Other conditions: HR+/HER2- Breast Cancer, Metastatic Disease, Аdvanced Disease
    View official trial listing →
  • Status unknown NCT NCT05800197

    Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia

    Blokhin's Russian Cancer Research Center 300 participants Est. completion 2025-01-15 1 site
    Other conditions: Breast Cancer, Neoadjuvant Endocrine Therapy
    View official trial listing →
  • Completed NCT NCT05865262

    Protocol TRANS and QT Repolarization

    University Hospital, Bordeaux 120 participants Est. completion 2023-01-01 1 site
    Other conditions: Transgender Individuals, QTc Interval
    View official trial listing →
  • Active, not recruiting NCT NCT05870579

    [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

    Not yet reported Novartis Pharmaceuticals 28 participants Est. completion 2032-05-27 13 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05887297

    Impact of Cognitive Behavioural Therapy for Insomnia on Endocrine Therapy Adherence

    Not yet reported University of Strathclyde 35 participants Est. completion 2024-04-23 1 site
    Other conditions: Insomnia, Breast Cancer, Adherence, Medication, Quality of Life, Survivorship
    View official trial listing →
  • Active, not recruiting NCT NCT05891795

    Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy

    Not yet reported, Not yet reported Stanford University 18 participants Est. completion 2026-06 1 site
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Status unknown NCT NCT05927779

    Study of TFX06 in Women With Advanced Breast Cancer.

    Not yet reported, Not yet reported Zhejiang Yangli Pharmaceutical Technology Co., Ltd. 74 participants Est. completion 2025-04-30 2 sites
    Other conditions: ER+, HER2- Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05934877

    ASK-PrEP (Assistance Services Knowledge-PrEP)

    Not yet reported Friends Research Institute, Inc. 152 participants Est. completion 2025-03-19 1 site
    Substance use disorder Other conditions: HIV
    View official trial listing →
  • Active, not recruiting NCT NCT05952557

    An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

    Not yet reported AstraZeneca 5511 participants Est. completion 2037-05-06 661 sites
    Other conditions: Breast Cancer, Early Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05982470

    Effect of Menopause Hormone Therapy In Postmenopausal Women With CSVD And MCI

    Not yet reported Beijing Tiantan Hospital 328 participants Est. completion 2025-10-01 1 site
    Other conditions: Cerebral Small Vessel Diseases, Postmenopausal Symptoms, Mild Cognitive Impairment, White Matter Hyperintensity
    View official trial listing →
  • Completed NCT NCT06009627

    Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients

    Not yet reported, Not yet reported Tianjin Medical University Cancer Institute and Hospital 119 participants Est. completion 2025-09-11 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06016738

    OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

    Not yet reported Olema Pharmaceuticals, Inc. 510 participants Est. completion 2028-02-29 233 sites
    Other conditions: Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT06040593

    Study of Predictors of Clinical Outcomes in Patients With HR+ and HER2-low/Negative Breast Cancer

    Daiichi Sankyo 927 participants Est. completion 2024-02-23 1 site
    Other conditions: Hormone-receptor-positive Breast Cancer, HER2-low Breast Cancer, HER2-negative Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06061666

    Treatment of Insomnia in Patients With Breast Cancer

    Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 80 participants Est. completion 2024-06-30 1 site
    Other conditions: Breast Cancer, Insomnia
    View official trial listing →
  • Completed NCT NCT06064851

    Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Patients With and Without Von Willebrand Disease

    Not yet reported Five Liters, Inc. 29 participants Est. completion 2025-04-18 1 site Stand-alone
    Other conditions: Von Willebrand Disease, Type 1, Heavy Menstrual Bleeding
    View official trial listing →
  • Active, not recruiting NCT NCT06065748

    A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

    Not yet reported Hoffmann-La Roche 1050 participants Est. completion 2029-02-12 311 sites
    Other conditions: Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT06075758

    A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer

    Novartis Pharmaceuticals 175 participants Est. completion 2025-06-30 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06105632

    A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

    Not yet reported Pfizer 333 participants Est. completion 2028-01-21 48 sites
    Other conditions: Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT06116201

    Influences of Long Term Hormone Therapy on Physical Fitness and Vascular Function in Transgender Women

    Not yet reported Chulalongkorn University 60 participants Est. completion 2021-07-31 1 site
    Other conditions: Transgender Women
    View official trial listing →
  • Terminated NCT NCT06126003

    Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer.

    BioCorteX Inc 2 participants Est. completion 2024-07-31 6 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT06131424

    NIS Study Determining Prevalence of HER2-low in Metastatic Breast Cancer Patients

    AstraZeneca 1151 participants Est. completion 2025-05-19 31 sites
    Other conditions: HER2-negative
    View official trial listing →
  • Active, not recruiting NCT NCT06148506

    A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia

    Novartis Pharmaceuticals 376 participants Est. completion 2027-06-30 20 sites
    Other conditions: HR+HER2- Advanced Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06223698

    Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast Cancer

    Not yet reported Region Örebro County 3832 participants Est. completion 2035-05-02 15 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06229366

    [Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer

    Not yet reported Eli Lilly and Company 142 participants Est. completion 2032-12 7 sites
    Other conditions: Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Oligometastatic Prostate Carcinoma, Hormone Sensitive Prostate Cancer
    View official trial listing →
  • Completed NCT NCT06311383

    A Non-interventional Study for Women With HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer to Evaluate the Real-world Effectiveness of Treatment Algorithms Beginning With Ribociclib + AI/FUL, or With Endocrine Therapy or Chemotherapy as First Line Treatment

    Novartis Pharmaceuticals 2610 participants Est. completion 2025-03-10 265 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT06379659

    Effectiveness of Intrauterine Growth Hormone Administration as an add-on Therapy to Conventional Hormone Therapy Compared to Placebo in Patients With Thin Endometrium Undergoing Frozen Thawed Embryo Transfer

    Not yet reported, Not yet reported Isfahan University of Medical Sciences 54 participants Est. completion 2024-09-14 1 site
    Other conditions: Thin Endometrium, Infertility Female, Infertility
    View official trial listing →
  • Not yet recruiting NCT NCT06407401

    Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 399 participants Est. completion 2028-11-30
    Other conditions: ER+ Breast Cancer, HER2-negative Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, Drug-Related Side Effects and Adverse Reactions, Musculoskeletal Pain
    View official trial listing →
  • Active, not recruiting NCT NCT06428396

    Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)

    Not yet reported Merck Sharp & Dohme LLC 120 participants Est. completion 2028-12-25 41 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06440967

    A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy

    Not yet reported Astellas Pharma Global Development, Inc. 982 participants Est. completion 2028-04-30 110 sites
    Other conditions: Hot Flashes
    View official trial listing →
  • Status unknown NCT NCT06455956

    Use of miRNAs in Growth Hormone Deficiency (GHD)

    University of Parma 400 participants Est. completion 2026-03-01 1 site
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Completed NCT NCT06464341

    Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO Study

    University Hospital, Basel, Switzerland 583 participants Est. completion 2024-12-31 62 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Enrolling by invitation NCT NCT06481956

    T-DM1 Combined With CDK4/6 Inhibitor Ribociclib

    Not yet reported Zheng Yabing 40 participants Est. completion 2027-10-10 1 site
    Other conditions: HER2-positive Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT06500741

    Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer Patients

    Astellas Pharma Global Development, Inc. 374 participants Est. completion 2025-04-02 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Withdrawn NCT NCT06585969

    A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer

    Not yet reported Danish Breast Cancer Cooperative Group Est. completion 2026-01-01
    Other conditions: Metastatic Breast Cancer, ER-positive Breast Cancer, Luminal B, Her2 Enriched, Basal Like
    View official trial listing →
  • Completed NCT NCT06603805

    Optimal Surgical Approach for Early-Stage Breast Cancer in Chinese Patients Aged ≤ 40 Years: a Cohort Study

    West China Hospital 974 participants Est. completion 2024-01-01
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT06655545

    18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer Patients

    Fudan University 473 participants Est. completion 2025-02-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT06656624

    Efficacy and Safety of Ribociclib Combined With AI Versus Physician&Amp;#39;s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expression/HER2-negative Advanced Breast Cancer (Rachel)

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 190 participants Est. completion 2025-12-31 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Completed NCT NCT06690489

    An Observational Real-world Study to Evaluate the Impact of Dermatological Toxicities on the Quality of Life in Patients With Early Breast Cancer Treated With Adjuvant Endocrine Therapy - BCARE (Breast Cancer Adjuvant Real-world Evaluation of Dermatological Adverse Events)

    Pierre Fabre Medicament 155 participants Est. completion 2025-11-26 9 sites
    Other conditions: Early Breast Cancer, Skin Condition, Quality of Life
    View official trial listing →
  • Enrolling by invitation NCT NCT06733415

    Changes in Energy Expenditure (EE) in Transsexuals Undergoing Hormonal Therapy

    Tel-Aviv Sourasky Medical Center 40 participants Est. completion 2026-12-31 1 site
    Other conditions: Transgender, Transgender Persons, M01.777.500
    View official trial listing →
  • Not yet recruiting NCT NCT06787118

    Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 130 participants Est. completion 2027-05 1 site
    Other conditions: Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, HR+ Breast Cancer, AI-related Musculoskeletal Pain
    View official trial listing →
  • Not yet recruiting NCT NCT06806072

    BALNEOTHERAPY FOR BREAST CANCER PATIENTS UNDERGOING ENDOCRINE THERAPY

    Not yet reported Parc de Salut Mar 96 participants Est. completion 2027-05-31 1 site
    Other conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)
    View official trial listing →
  • Completed NCT NCT07013422

    The Effectiveness of Psychoeducational Intervention in Reducing Anxiety, Depression, and Symptom Burden Among Omani Women Diagnosed With Breast Cancer

    Not yet reported Sultan Qaboos Comprehensive Cancer Center 58 participants Est. completion 2024-04-18 1 site Stand-alone
    Other conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3)
    View official trial listing →
  • Not yet recruiting NCT NCT07078435

    Innate Immunity, MIcrobiota and Inovative Treatments in Endometriosis

    Not yet reported University Hospital, Grenoble 40 participants Est. completion 2027-09-30 1 site
    Other conditions: Endometriosis, Immunity, Microbiota
    View official trial listing →
  • Enrolling by invitation NCT NCT07128771

    Cardiomodulatory Effects of Gender-Affirming Hormone Therapy

    University Hospital, Akershus 450 participants Est. completion 2030-10 1 site
    Cardiovascular disease Other conditions: Gender Incongruence
    View official trial listing →
  • Not yet recruiting NCT NCT07164794

    Memantine Hydrochloride in Prostate Cancer Patients

    Not yet reported Bin Xu 15 participants Est. completion 2028-06
    Other conditions: Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostate Cancer, Neuroendocrine Prostate Cancer (NEPC)
    View official trial listing →
  • Not yet recruiting NCT NCT07179939

    Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study

    Not yet reported Fudan University 288 participants Est. completion 2031-12-30 1 site
    Other conditions: HER2-positive Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07190651

    Development of a New Remote Monitoring Model for Patients With HR+HER2- Breast Cancer in Treatment With CDK4/6 Inhibitors and Hormone Therapy

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50 participants Est. completion 2026-09-30
    Other conditions: Breast Cancer, CDK4/6 Inhibitor
    View official trial listing →
  • Not yet recruiting NCT NCT07213206

    CDK4/6 Inhibitor Intensification and Chemotherapy De-Escalation for Early-stage Luminal-HER2 Breast Cancer

    Not yet reported Fudan University 1500 participants Est. completion 2035-09-01
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07235618

    A Study of Entinostat in Combination With Fulvestrant for the Treatment of Locally Advanced or Metastatic Breast Cancer

    Not yet reported Sun Yat-sen University 50 participants Est. completion 2028-12-30 1 site
    Other conditions: Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07269691

    RaSOLVE: 125I Radioactive Seed Marking Effects on Pathological Complete Response Rate and Prognosis Post-Neoadjuvant Therapy in Early/Advanced Breast Cancer

    Not yet reported Pengfei Qiu 194 participants Est. completion 2027-12-01 1 site
    Other conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3), Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07311122

    Endocrine Therapy Base on 21-gene RS

    Gangnam Severance Hospital 4000 participants Est. completion 2028-12-31
    Other conditions: Breast Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT07352748

    Exploiting Heterogeneity in Hormone Therapy Response to Reveal Early Determinants of Drug Resistance in Advanced PCa

    Universita di Verona 30 participants Est. completion 2026-10-17 1 site
    Other conditions: Metastatic Prostate Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07376057

    Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 150 participants Est. completion 2028-12-31 1 site
    Other conditions: Prostatic Neoplasms, Castration-Resistant
    View official trial listing →
  • Not yet recruiting NCT NCT07389174

    Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer

    Not yet reported Shanghai Changzheng Hospital 40 participants Est. completion 2027-06 1 site
    Other conditions: mHSPC, mHNPC, Prostate Cancer Adenocarcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT07394400

    Effects of Gender-Affirming Hormone Therapy on Cardiovascular, Metabolic, and Mental Health Outcomes in Transgender Adults.

    Milagros Rocha Barajas 94 participants Est. completion 2029-12-31 1 site
    Other conditions: Transgender Individuals
    View official trial listing →
  • Not yet recruiting NCT NCT07394946

    Neoadjuvant Letrozole in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative, Node Positive, Early-Stage Breast Cancer.

    Not yet reported Cancer Care Hospital & Research Centre Foundation, Lahore 126 participants Est. completion 2029-07 1 site
    Other conditions: Hormone Receptor-Positive, HER2-Negative, Node Positive Breast Cancer
    View official trial listing →
  • Enrolling by invitation NCT NCT07422727

    Impact of Cooling Mats on Vasomotor Symptoms in Patients Receiving Endocrine Therapy

    Not yet reported Sligo General Hospital 40 participants Est. completion 2026-04-01 1 site
    Other conditions: Hot Flashes, Sleep, Hormonal, Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07529353

    Feasibility of 'Exercise for CAncer Patients and Healthy EAting Timeframes' .

    Not yet reported University of Rochester 20 participants Est. completion 2028-10 1 site
    Other conditions: Breast Cancer, Cancer Related Fatigue
    View official trial listing →
  • Not yet recruiting NCT NCT07545486

    Ablative Therapy of Oligometastatic Tumor After Response to Conventional First Line Treatment

    Chirec 1235 participants Est. completion 2036-06-01 12 sites
    Other conditions: Solid Tumor
    View official trial listing →
  • Not yet recruiting NCT NCT07572981

    Study of the Effectiveness of Clinical Hypnosis and Self-hypnosis in Relieving Hot Flashes in Menopausal Women

    Not yet reported University Hospital, Toulouse 94 participants Est. completion 2027-12-31 1 site
    Other conditions: Menopause
    View official trial listing →
  • Enrolling by invitation NCT NCT07586319

    Effectiveness of Surgery for Improving Survival in Oligometastatic Breast Cancer Patients

    Not yet reported Sharif Medical Research Center 110 participants Est. completion 2031-06-01 1 site
    Other conditions: Survival Outcomes
    View official trial listing →
  • Not yet recruiting NCT NCT07668427

    The Impact of a Web-based Empowerment Program on Intolerance of Uncertainty and Maintenance Burden.

    Not yet reported Necmettin Erbakan University 62 participants Est. completion 2027-05-17
    Other conditions: Intolerance of Uncertainty, Caregiving Burden
    View official trial listing →
  • Not yet recruiting NCT NCT07677956

    Safety of Breast-Conserving Surgery for Multifocal or Multicentric Breast Cancer

    The First Affiliated Hospital with Nanjing Medical University 100 participants Est. completion 2036-12-30
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07738341

    GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ)

    Not yet reported, Not yet reported Eddingpharm (Zhuhai) Co., Ltd. 270 participants Est. completion 2030-08-01
    Other conditions: Breast Cancer (Locally Advanced or Metastatic)
    View official trial listing →
  • Not yet recruiting NCT NCT07754292

    Off-Label Treatment With Immune Checkpoint Inhibitor Blockade

    Not yet reported Medical College of Wisconsin 231 participants Est. completion 2036-11-01 1 site Stand-alone
    Other conditions: Malignancy
    View official trial listing →
  • Not yet recruiting NCT NCT07759947

    Telehealth Intervention for Symptom Management and Adherence to Adjuvant Endocrine Therapy

    Not yet reported Massachusetts General Hospital 400 participants Est. completion 2031-06-01 2 sites
    Other conditions: Hormone Receptor Positive Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07773662

    Age of Puberty Onset Among Girls in Asyut, Egypt

    Assiut University 600 participants Est. completion 2027-10
    Other conditions: Puberty
    View official trial listing →
  • Not yet recruiting NCT NCT07840534

    Patient-Initiated Follow-Up for Women After Early Breast Cancer Treatment (LYSA2PIFU)

    Not yet reported University College Cork 30 participants Est. completion 2028-06-01 1 site
    Other conditions: Breast Cancer, Breast Cancer Survivorship, Cancer Survivorship, Endocrine Therapy, Early Stage Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07844759

    SOLIS: Single-Dose Radiotherapy With Omission of Lumpectomy for Intact Small Breast Cancers

    Not yet reported Renaissance Institute of Precision Oncology and Radiosurgery 30 participants Est. completion 2032-01-01 1 site
    Other conditions: Breast Cancer, Early-Stage Breast Carcinoma, Hormone Receptor-Positive Breast Cancer, HER2-Negative Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07859319

    Evaluation of the Efficacy and Acceptability of a Phytotherapy Combining Devil's Claw, Blackcurrant and Meadowsweet for the Management of Aromatase Inhibitor-induced Arthralgia in Patients Treated for Localized Breast Cancer in the Adjuvant Setting

    Not yet reported Hospices Civils de Lyon 105 participants Est. completion 2028-03 3 sites
    Other conditions: Hormone Therapy-induced Arthralgia, Phytotherapy, Symptom Management, Adjuvant Treatment, Patient Acceptability, Joint Pain
    View official trial listing →
  • Not yet recruiting NCT NCT07905001

    A Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast Cancer

    Not yet reported Prelude Therapeutics Incorporated 242 participants Est. completion 2029-10-31
    Other conditions: Breast Cancer, Hormone-receptor-positive Breast Cancer, HER2-negative Breast Cancer, HR-positive Breast Cancer, HR+/HER2- Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07907653

    Deutenzalutamide and Hormone Therapy Before and After Surgery With Docetaxel Before Surgery for High-Risk Localized or Locally Advanced Prostate Cancer

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 37 participants Est. completion 2035-01 1 site
    Other conditions: Prostate Cancer (Adenocarcinoma)
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.